| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review |
Division of Endocrinology, Department of Internal Medicine and the Center for Research in Reproduction, University of Virginia, Charlottesville, VA 22908, USA
(Requests for offprints should be addressed to L L Burger; Email: lburger{at}virginia.edu)
 |
Abstract |
|---|
 Top Abstract IntroductionPhysiologic changes in subunit...Gonadotropin subunit regulation...Regulation of subunit gene...Regulation of FSHß...References |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionPhysiologic changes in subunit...Gonadotropin subunit regulation...Regulation of subunit gene...Regulation of FSHß...References |
|---|
(common to both), and LHß and FSHß, which are coded by three genes located on separate chromosomes (Chin 1987, Gharib et al. 1990b). LH and FSH are secreted by the pituitary gonadotropes and act on the gonad in a sequential and synergistic manner to initiate sexual maturation and maintain cyclic reproductive function (Bäckström et al. 1982, Marshall & Kelch 1986, Wu et al. 1990). The synthesis and secretion of the gonadotropins are regulated primarily by the hypothalamic decapeptide gonadotropin-releasing hormone (GnRH), which is secreted into the hypophyseal-portal circulation in a pulsatile manner (Clarke & Cummins 1982, Levine & Ramirez 1982). The control of LH and FSH synthesis and secretion is complex and involves interplay between the gonads, pituitary and hypothalamus. LH and FSH act on the ovaries and the testes to regulate folliculogenesis, ovulation, spermatogenesis and steroidogenesis. Gonadal steroids and peptides, in turn, act at the hypothalamus and/or pituitary to regulate either positively or negatively LH and FSH synthesis and secretion. The aims of this review are to present the transcriptional regulation of the gonadotropin subunit genes in a physiologic setting and examine the mechanisms that drive those changes. |
Physiologic changes in subunit gene transcription |
|---|
|
TopAbstractIntroductionPhysiologic changes in subunit...Gonadotropin subunit regulation...Regulation of subunit gene...Regulation of FSHß...References |
|---|
Changes in gonadotropin subunit mRNA expression have been determined over the course of the estrous cycle in rats and mice. In rats, we have shown that LHß and FSHß mRNAs increase during the time of preovulatory gonadotropin surge. The increase in LHß mRNA precedes that of FSH ß; LHß mRNA began increasing around 1400 h, before the beginning of the LH surge; was maximal at 1700 h; and had returned to basal by 2200 h (Zmeili et al. 1986, Kerrigan et al. 1995). FSHß mRNA did not increase until about 2200 h, 2 h after the increase in serum FSH, and was maximal at 0200 h during estrus and had returned to basal by 0800 h (Ortolano et al. 1988). In contrast, mRNA did not change during the preovulatory surge (Zmeili et al. 1986). The periovulatory changes in the ß-subunit mRNAs are coincident with increased GnRH secretion (Levine & Ramirez 1982) and result from increased gene transcription. ß-subunit mRNA synthesis, as measured by nuclear run-on assays, was found to be greatest during proestrus for LHß, and during late proestrus and estrus for FSHß (Shupnik et al. 1989a). Similarly, FSHß promoter activity was increased on estrus (versus metestrus) in transgenic mice harboring an ovine FSHß promoter-luciferase (LUC) reporter gene (Huang et al. 2001a,b).
In addition to the changes in subunit mRNAs that occur around the preovulatory gonadotropin surge, FSHß mRNA expression increased at metestrus, and both and LHß mRNAs increased in parallel during diestrus, periods when serum LH and FSH levels are low. The mechanism(s) for the these changes are not well understood, but probably reflect the sensitivity of the subunit genes to differences in GnRH pulse frequencies and steroid milieu; and for FSHß, changes in serum and/or intrapituitary inhibin, activin or follistatin (FS).
Gonadectomy
Several studies have shown that gonadotropin subunit gene expression is differentially regulated after gonadectomy. The loss of negative feedback by sex steroids at the hypothalamus results in increased GnRH pulse amplitude and frequency (Levine & Ramirez 1982). This increase in GnRH drives expression of all three subunit genes, but there are significant differences in the magnitudes of change and timing, both among the subunits and between the sexes.
In male rats, castration (CAST) results in a rapid increase in serum LH, reflecting an increase in GnRH secretion. Coincident with the increase in GnRH, all three subunit mRNAs are elevated 24 h after CAST (Papavasiliou et al. 1986, Dalkin et al. 2001, Burger et al. 2004). Whereas and LHß mRNA concentrations continue to increase steadily after CAST (Papavasiliou et al. 1986, Dalkin et al. 1990), increases in FSHß mRNA are more modest and begin to decline by day 7 (Gharib et al. 1987, Dalkin et al. 1990).
The increases in subunit mRNA after CAST are regulated in part at the level of transcription. We have recently investigated the changes in subunit gene transcription after CAST by measuring subunit primary transcript (PT) concentrations (Fig. 1
). These transcripts are newly formed RNA that include both exon and intron sequences, prior to RNA splicing, and thus are closely linked to gene transcription and mRNA formation (Dalkin et al. 2001). After CAST, LHß PT increases within 8 h and remains elevated (Dalkin et al. 2001, Burger et al. 2004). Similarly, LHß promoter activity has been reported to increase after CAST in transgenic mice harboring either a rat LHß promoter-LUC construct (Fallest et al. 1995) or an ovine LHß-chloramphenicol acetyltransferase (CAT) reporter (McNeilly et al. 1996). Although FSHß mRNA was elevated within 24 h of CAST, we did not observe an acute increase in FSHß PT (Burger et al. 2004). However, FSHß transcription was increased 5–7 days after CAST, as measured by either nuclear run-on assays (Paul et al. 1990), PT (Dalkin et al. 2001) or FSHß promoter activity in transgenic mice carrying an ovine FSHß-LUC reporter gene (Huang et al. 2001a,b). In contrast, changes in endogenous gene transcription after CAST are not consistent; we have reported that PT was unchanged at day 7 (Dalkin et al. 2001), whereas mRNA synthesis was increased on day 5 (Paul et al. 1990). Additionally, promoter activity increased after CAST in transgenic mice carrying either a human or bovine promoter-CAT reporter (Clay et al. 1993); in vitro, the activity of a human promoter-LUC reporter was greater when transfected into pituitary cells from male rats that had been CAST for 7–21 days (versus intact male rats) (Colin et al. 1996).
|
) (Burger et al. 2004). Similarly, in transgenic mice, either GnRH antagonist or testosterone suppressed the post-CAST increases in rat LHß-LUC (Fallest et al. 1995), ovine LHß-CAT (McNeilly et al. 1996), and both human and bovine -CAT promoter constructs (Clay et al. 1993). The elevated transcription rates seen after CAST require sustained GnRH input. Administration of a GnRH antagonist to 7-day CAST rats rapidly reduced LHß and FSHß PT, with half-disappearance times of 2.7 and 0.75 h respectively (Fig. 2) (Dalkin et al. 2001).
|
and LHß mRNA expression begins to rise about day 3, and continues to rise through day 21 (Dalkin et al. 1990, 1993, Burger et al. 2001). In contrast, both serum FSH and FSHß mRNA increase rapidly after OVX; serum FSH doubles by 8 h and FSHß mRNA by 30–60 min (Dalkin et al. 1993), and they continue to rise through day 7 (Dalkin et al. 1990, 1993, Burger et al. 2001). As in males, increased subunit mRNA levels result from elevated transcription rates; mRNA synthesis rates were increased for all three subunits in 30-day OVX rats (Shupnik et al. 1988). Recently, we have examined the changes in subunit transcription in the 7 days after OVX during the dynamic period after the loss of gonadal feedback (Fig. 3) (Burger et al. 2001). We found that LHß PT concentrations were increased after day 3, paralleling changes in serum LH and LHß mRNA. In contrast, there was a biphasic change in serum FSH, FSHß mRNA and FSHß PT after OVX, with an acute increase at 12–24 h, followed by an additional increase after 72 h. Although mRNA was elevated after OVX, as in our earlier studies in males, -PT did not change.
|
and LHß mRNA synthesis rates significantly, but had either no effect or a modest suppression on FSHß in long-term OVX rats (Shupnik et al. 1988, 1990, Fallest & Shupnik 1994). Similarly, we found that GnRH blockade prevented the post-OVX increase in LHß-PT, but had no effect on the acute (12–24-h) increase in FSHß-PT and only partially suppressed the increase in FSHß PT after day 3 (Fig. 4). Sustained GnRH secretion is also required to maintain post-OVX increases in ß-subunit transcription; giving a single dose of GnRH antagonist to 7-day OVX rats rapidly reduced both LHß and FSHß PT, with half-disappearance times of 13 and 17 min respectively (Fig. 5).
|
|
and LHß transcription after OVX appear to be largely regulated by GnRH, control of FSHß transcription is more complex. The modest effect of either GnRH antagonist or E2 in suppressing FSHß transcription in vivo, hinted at a role for inhibin, activin and/or FS. We previously showed that administration of inhibin- antisera to intact female rats mimics the GnRH-independent increases in FSH and FSHß mRNA that occur within hours after OVX (Dalkin et al. 1993, 1998). Similarly, we found that FSHß PT levels increased rapidly after inhibin immunoneutralization and were suppressed in OVX rats treated with recombinant human inhibin, suggesting that inhibin suppresses FSHß transcription (Burger et al. 2001). However, we also found that inhibin suppressed FSHß mRNA levels much faster than after a GnRH antagonist, suggesting that inhibin may also affect FSHß mRNA stability.
Several transgenic mouse models have been used to investigate the effects of OVX on subunit promoter activity. Hamernik et al.(1992) reported CAT that E2 suppressed activity of either human or bovine CAT constructs in OVX mice and that OVX levels could be restored with pulsatile GnRH. Activity of rat, ovine and bovine LHß promoter–reporter constructs increased after OVX in transgenic mice, and were suppressed by either GnRH antagonist (Fallest et al. 1995, Quirk et al. 2001) or E2 (Fallest et al. 1995, McNeilly et al. 1996). Huang et al. (2001a, b) reported that FSHß promoter activity is increased after OVX in transgenic mice harboring an ovine FSHß –LUC construct.
|
Gonadotropin subunit regulation by GnRH |
|---|
|
TopAbstractIntroductionPhysiologic changes in subunit...Gonadotropin subunit regulation...Regulation of subunit gene...Regulation of FSHß...References |
|---|
A central question in studying the physiology of the gonadotropins is how a single hormone (GnRH) acting on a single cell type (gonadotrope) can differentially regulate two hormones (LH and FSH). The answer is that GnRH differentially regulates LH and FSH synthesis via changes in the pattern of GnRH pulse secretion. Our laboratory and others have investigated the effects of GnRH pulse amplitude and frequency on subunit mRNA expression both in vivo and in vitro. In GnRH-deficient male rats, fast-frequency GnRH pulses (every 8 min) favored expression of and, to a lesser extent, LHß mRNA, fast-physiologic GnRH pulses (every 30 min, the approximate frequency of GnRH pulses found in CAST male rats or intact female rats on the afternoon of proestrus (Levine & Duffy 1988, Levin & Ramirez 1982) increased all three subunit mRNAs, and slow-frequency pulses (>120-min intervals) selectively increased FSHß mRNA (Haisenleder et al. 1988, Dalkin et al. 1989, Kirk et al. 1994). GnRH pulse amplitude also differentially regulates subunit mRNA, though to a lesser extent than pulse frequency; only LHß mRNA expression was sensitive to GnRH pulse amplitude and was maximally stimulated by GnRH pulse doses of 25 ng or less (Haisenleder et al. 1988, Iliff-Sizemore et al. 1990).
GnRH regulation of subunit mRNA is somewhat different in female rats. In initial studies, we reported that GnRH pulses increased and FSHß mRNA levels, but not LHß in GnRH-deficient OVX rats (Kerrigan et al. 1993), a finding which was consistent with the lack of LHß mRNA response to GnRH reported in cultured pituitary cells from OVX rats (Weiss et al. 1990). Subsequently, we found that testosterone was required for GnRH pulses to increase LHß mRNA in OVX rats, and that the optimal dose of testosterone was similar to levels seen at proestrus (Yasin et al. 1996). Although testosterone is required in females, it is not acutely required in males, as GnRH increased LHß mRNA in short-term CAST males with or without T (Yasin et al. 1996). On a background of proestrus T levels, we have found that GnRH pulse amplitude and frequency differentially regulate subunit mRNA expression in females similar to males. Alpha and FSHß mRNAs were increased by a wider range of GnRH pulse amplitudes, while LHß mRNA was maximally stimulated by lower GnRH pulse doses (Dalkin et al. 1999). Fast-physiologic GnRH frequencies (8–120-min intervals) stimulated all three subunit mRNAs, but only slow-frequency GnRH pulses (every 240 min) increased FSHß (Dalkin et al. 1999). The effects of GnRH pulse amplitude and frequency have also been examined in cultured pituitary cells. In female rat pituitary cells, only mRNA increased with high-amplitude GnRH pulses, whereas LHß and FSHß mRNAs responded to lower doses of GnRH (Haisenleder et al. 1993a). In male pituitary cells, ß mRNA was increased by all GnRH pulse frequencies examined, LHß mRNA was maximally stimulated by pulses every 30 min, and FSHß mRNA was greatest after 120-min pulses (Kaiser et al. 1997b).
Although there is some evidence that GnRH may regulate subunit mRNA concentrations via mRNA stability (Salton et al. 1988, Weiss et al. 1992), GnRH appears to exert its main action at the transcriptional level. While continuous GnRH stimulated transcription in vitro (Shupnik 1990), a pulsatile GnRH input was required to increase ß-subunit transcription both in vivo (Haisenleder et al. 1991) and in vitro (Shupnik 1990, Shupnik & Fallest 1994). Furthermore, pulsatile GnRH increased ß-subunit transcription in a frequency-dependent manner. Faster GnRH pulse frequencies (
60-min interpulse interval) preferentially increased LHß mRNA synthesis or PT levels both in vitro (Shupnik 1996) and in vivo (Haisenleder et al. 1991, Burger et al. 2002). In contrast, slower GnRH pulse frequencies (60-min intervals) preferentially increased FSHß transcription. Alpha-subunit transcription does not appear to be tightly regulated by GnRH pulse frequency, some studies indicating that transcription is favored by fast-frequency GnRH pulses (Haisenleder et al. 1991, Shupnik et al. 1996), and others showing that fast and slow frequencies are equally effective (Haisenleder et al. 2001, 2003a, Burger et al. 2002).
The effects of a GnRH pulse on subunit transcription are both rapid and transient. In male rats, LHß and FSHß PTs increased six- and fourfold 5 min after a GnRH pulse, and declined to basal levels by 30 min, with FSHß PT decreasing faster than LHß PT (Dalkin et al. 2001). Although PT tended to increase 5–15 min after a GnRH pulse, the rise was not statistically significant. The duration of GnRH pulsatile treatment also appears to be important in regulating subunit transcription rates. In earlier studies, we found that GnRH pulses given every 30 min to male rats increased , LHß and FSHß mRNA synthesis rates, but that the increases in LHß and FSHß returned to basal at 4–24 h (Haisenleder et al. 1991). In a more recent study, we found that only fast-frequency GnRH pulses (30 min) increased LHß PT levels, and that the increase in transcription was sustained after 1–24 h of pulses (Fig. 6) (Burger et al. 2003). Unexpectedly, we found that both fast- and slow-(240-min) frequency GnRH pulses increased FSHß PT, but with significantly different time courses. Fast-frequency GnRH pulses transiently increased FSHß PT after 1–6 h, but returned to control levels by 24 h. In contrast, slow-frequency GnRH pulses resulted in a delayed but sustained increase in FSHß PT at 8–24 h, and only 240-min pulses increased both FSHß PT and mRNA expression.
|
60 min) stimulated expression of a rat LHß promoter-reporter to a greater degree than slower frequencies. In contrast, a rat FSHß promoter-reporter was preferentially stimulated by slower GnRH pulse frequencies (60 min), but a clear preference for a slower GnRH frequency was not observed until after 20 h of pulses, before which fast GnRH frequencies were as effective if not better in stimulating FSHß promoter activity (Bedecarrats & Kaiser 2003). Alpha promoter activity was also stimulated by GnRH in LßT2 cells but was less frequency dependent than the ß-subunits; human -LUC reporter activity increased with all GnRH frequencies but was greatest with more frequent GnRH pulses (Bedecarrats & Kaiser 2003). Intracellular mechanisms of subunit gene transcription by GnRH
The GnRH receptor (GnRH-R) is a member of the seven-transmembrane receptor family, with receptor binding activating two specific GTP-binding proteins (Gq, G11) (Hsieh & Martin 1992, Stojilkovic & Catt 1995b, Kaiser et al. 1997a, Liu et al. 2002b). GnRH-R activation stimulates increased phosphoinositide turnover and a rise in intracellular diaclyglycerol levels, resulting in the activation of protein kinase C (PKC) (Andrews & Conn 1986, Stojilkovic & Catt 1995a). Activation of the GnRH-R also stimulates a transient rise in intracellular calcium, derived from inositol 1,4,5-triphosphate-induced release from intracellular storage pools and from influx via voltage-sensitive(L-type) channels (Naor 1990, Ando et al. 2001). GnRH also stimulates an increase in cAMP (Bourne 1988, Garrel et al. 1997) and activates members of the mitogen-activated protein kinase (MAPK) family, including extracellular signal-regulated kinase (ERK) (Mitchell et al. 1994, Roberson et al. 1995, Sundaresan et al. 1996, Reiss et al. 1997), c-Jun NH2-terminal kinase (JNK) (Levi et al. 1998, Roberson et al. 1999, Yokoi et al. 2000) and p38 (Roberson et al. 1999, Liu et al. 2002a) in several species.
As discussed previously, gonadotropin subunit gene transcription is regulated in a differential manner by alterations in GnRH pulse frequency. Recent data suggest that various mammalian species express a second GnRH isoform (GnRH II) and GnRH-R (GnRH-R II) in the hypothalamus and pituitary (Neill 2002). Although effects on sexual behavior and preferential actions on FSH secretion have been described, the physiologic roles of these isoforms remain to be determined. The evidence to date suggests that differential synthesis and secretion of LH and FSH is the product of altered patterns of pulsatile GnRH I secretion by activation of pituitary GnRH-R I. Although the intracellular messengers responsible for transmitting frequency-dependent signals from the plasma membrane to the nucleus within the gonadotrope have yet to be fully characterized, recent findings have provided insights into critical sites in the signal transduction pathways involved.
cAMP
Activation of the cAMP pathway stimulates (mouse, rat and human) promoter activity (Maurer et al. 1999), and cAMP may also have a general stimulatory response to GnRH signaling. The mouse GnRH-R promoter contains two cAMP responsive element-binding (CREB) sites, and increased cAMP/protein kinase A (PKA) activity enhanced mouse GnRH-R promoter activity in lactotropic GH3 cells stably transfected with rat GnRH-R cDNA (GGH3 cell lines) (Han & Conn 1999, Lin & Conn 1999). However, studies conducted in either gonadotrope-derived T3 cells or transgenic mice models reveal that PKC, MAPK and activator protein-1 (AP-1) play a more prominent role in GnRH regulation of the GnRH promoter (Norwitz et al. 1999, White et al. 1999, Ellsworth et al. 2003). In the human model, CREB plays an essential role in GnRH activation of the promoter, and GnRH stimulates the phosphorylation of CREB (Delegeane et al. 1987, Duan et al. 1999). The porcine FSHß promoter also contains a putative CREB site (Kato et al. 1999). We have conducted in vitro studies in rat pituitary cells to determine whether cAMP stimulates gonadotropin subunit mRNA (Haisenleder et al. 1992). The results demonstrated that a diffusible cAMP analog stimulated a rise in , but not LHß or FSHß mRNA. Of interest, we showed that the pattern of cAMP input was critical, as pulsatile, but not continuous, cAMP enhanced mRNA expression. More recent studies suggest that the cAMP/PKA pathway plays a role in cross-talk between specific intracellular messenger systems (that is, PKC and ERK) in response to GnRH stimulation (Garrel et al. 1997, Han & Conn 1999, Lin & Conn 1999, Fowkes et al. 2002).
Calcium
The GnRH-induced increases in intracellular calcium play an essential role in gonadotropin secretion (Naor 1990, Stojilkovic & Catt 1995a,b). Studies in various species and experimental models have also shown that , LHß and FSHß gene expression are regulated by increases in intracellu-lar calcium (Ben Menahem & Naor 1994, Saunders et al. 1998, Weck et al. 1998). In the rat, calcium stimulates a rise in , LHß and FSHß mRNA levels (Ben Menahem & Naor 1994, Haisenleder et al. 1993b, 1997). Other reports reveal that calcium stimulates gonadotropin subunit transcriptional activation, including increases in and LHß transcription (as measured by nuclear run-on assay or promoter–luciferase construct assay) (Weck et al. 2000) and , LHß and FSHß PT (Haisenleder et al. 2001). In contrast, other investigations using GH3 cells that express GnRH-R (GGH3–1 cells) have shown that the response to calcium is selective, stimulating but not LHß and FSHß (Saunders et al. 1998). Another report found that calcium suppresses GnRH- or PKC-induced rat LHß promoter activity in LßT4 cells (Vasilyev et al. 2002a). The reasons for these different gonado-tropin subunit responses to calcium remain to be determined. However, it is likely that factors such as differences in cell model, promoter constructs used, experimental paradigms and the end products measured play a role in the outcomes seen.
Gonadotrope cells express spikes and oscillations in intracellular calcium, the patterns of which are altered by GnRH and linked to LH secretion (Holl et al. 1988, Tse & Hille 1992, Stojikovic & Catt 1995b). These observations are of interest, as in other cell types, alterations in intracellular calcium can play a role in the regulation of gene expression and activation of downstream mediators of signal transduction pathways (that is, ERK and calcium/ calmodulin-dependent kinase II (Ca/CaMK II)) (Villalobos et al. 1988, Gu & Spitzer 1995, Dolmetsch et al. 1997, De Koninck et al. 1998, Durham & Russo 2000). We have investigated whether alterations in intracellular calcium are involved in transmission of frequency-dependent signals from the plasma membrane to the nucleus, and whether these signals mediate the , LHß and FSHß transcriptional responses to pulsatile GnRH (Haisenleder et al. 2001). The model used cultured rat pituitary cells and pulses of the calcium channel activator, Bay K 8644, plus potassium chloride (BK+KCl) given at intervals of 15, 60 or 180 min for 6 h. Gonadotropin subunit PT was measured to determine transcriptional responses to treatment. BK+KCl pulses stimulated release of both LH and FSH with a similar pattern and magnitude to those seen after pulsatile GnRH. Alterations in the frequency of calcium pulse signals revealed that was selectively stimulated by faster (every 15 min) pulses of BK+KCl, with slower pulses being ineffective (Fig. 7). LHß PT was stimulated by 15-or 60-min pulses, but not 180-min pulses, of BK+KCl. In contrast, FSHß PT was maximally stimulated by the slower (180-min) pulse interval. This pattern of divergent gonadotropin subunit responses to pulse frequency is similar to previous findings for GnRH (Haisenleder et al. 1997). Thus, intermittent changes in intracellular calcium appear to be important in the transmission of GnRH signals, and may mediate the differential actions of pulse frequency on gonadotropin subunit gene expression.
|
, LHß and FSHß PT (Fig. 8) or rat and LHß promoter activity. These finding support the hypothesis that Ca/CaMK II is a downstream mediator of GnRH/calcium signaling within the gonadotrope.
|
, LHß and FSHß mRNAs and ß transcription (Ben Menahem & Naor 1994, Weck et al. 1998, Halvorson et al. 1999, Vasilyev et al. 2002a). We have shown that PKC stimulates and LHß gene expression in rat pituitary cells in vitro; however, unlike results seen for cAMP and calcium, a pulsatile signal pattern does not play a significant role (Haisenleder et al. 1995). Data from other investigations in gonadotrope-derived LßT2, LßT4 or T3 cells, or lactotrope-derived GGH3–1 cells, demonstrate that PKC mediates the , LHß and FSHß transcriptional response to GnRH (Sundaresan et al. 1996, Weck et al. 1998, Vasilyev et al. 2002a,b). Kaiser et al.(2000) reported that PKC stimulation of the rat LHß gene is mediated via actions on Egr-1 binding within the proximal GnRH responsive region of the LHß promoter. An investigation of the bovine LHß promoter showed that interactions between Egr-1, SF-1 and Ptx-1 mediate the response to PKC (Tremblay & Drouin 1999). PKC has also been shown to stimulate the expression of the Egr-1 gene (Wolfe & Call 1999). In contrast, -subunit transcriptional responses to PKC reflect activation of the MAPK pathway (as discussed below). Characterization of the ovine FSHß promoter showed that PKC activation is mediated through multiple responsive regions, including 2 AP-1 sites (Strahl et al. 1998). However, these sites do not appear to play an important role in regulating the ovine FSHß promoter in transgenic mice (Huang et al. 2001b). Of interest, responses of individual gonadotropin subunits to PKC stimulation have been shown to differ between published reports, posssibly reflecting differences in cell model or experimental paradigm (Saunders et al. 1998, Weck et al. 1998, Vasilyev et al. 2002a,b).
Mitogen-activated protein kinase (MAPK)
A number of investigators have shown that GnRH stimulates activation of various members of the MAPK family, including ERK 1 and 2 (Mitchell et al. 1994, Roberson et al. 1995, Sundaresan et al. 1996, Reiss et al. 1997), JNK (Levi et al. 1998, Roberson et al. 1999, Yokoi et al. 2000) and p38 (Roberson et al. 1999, Liu et al. 2002a). GnRH-induced activation of ERK is mediated through both PKC-dependent and PKC-independent pathways, including calcium (Roberson et al. 1995, Sundaresan et al. 1996, Reiss et al. 1997, Mulvaney et al. 1999). Moreover, ERK phosphorylates various transcription factors that may play roles in the regulation of gonadotropin subunit gene expression (such as c-Fos, c-Jun and the Ets protein – ELK-1 (Seger & Krebs 1995, Maurer et al. 1999, Liu et al. 2002a).
We conducted studies to determine whether ERK plays a role in the differential gonadotrope responses to physiologic GnRH stimulation (Haisenleder et al. 1998). Initial work examined whether a pulsatile signal pattern is required to maintain ERK responsiveness to GnRH over longer durations. Groups of adult GnRH-deficient rats were given pulses of GnRH every 60 min for 1–8 h in vivo, and were compared with animals that received a continuous GnRH infusion for the same duration. Pulsatile GnRH stimulated a two- to fourfold increase in ERK activity, which was maintained over the 8-h experimental duration. However, continuous GnRH stimulated a transient rise in ERK only for the initial 2 h (Fig. 9). Follow-up studies showed that ERK activity is sensitive to GnRH pulse frequency, with slower (120-min) interval pulses being more effective than faster (30- or 60-min) interval pulses. To determine the role of ERK in mediating GnRH-induced stimulation of gonadotropin subunit gene expression, GnRH pulses were administered to rat pituitary cells in vitro, with or without the ERK inhibitor, PD-098059 (PD). As shown in Fig. 10, PD blocked the GnRH-induced rise in , FSHß and GnRH-R mRNAs, but not LHß. This suggests that GnRH-induced stimulation of LHß utilizes a distinct and different intracellular pathway or pathways. It is interesting to note that ERK is maximally stimulated by slower GnRH pulse intervals, and plays an important role in regulating the expression of two gonadotrope genes that are also maximally stimulated by slower GnRH pulse intervals (FSHß and GnRH-R).
|
|
T3 cells revealed that PKC mediates the GnRH-induced activation of p38 (Roberson et al. 1999). However, while p38 activates downstream pathways known to stimulate gene expression (Maurer et al. 1999), published reports suggest that the signal transduction protein does not stimulate promoter activity (Roberson et al. 1999). Whether p38 regulates the expression of the LHß and FSHß genes remains to be determined.
In summary, present information suggests that differential regulation of gonadotropin subunit gene expression by GnRH involves several mechanisms. GnRH may exert selective actions on specific signal transduction pathways (such as ERK regulation of and FSHß, but not LHß). Alternatively, the responses may reflect differential sensitivity to intracellular messenger systems (for example, specific gonadotropin subunit genes may be more sensitive to calcium or PKC pathways than other subunit genes). Furthermore, it is likely that the role played by GnRH pulse frequency is selectively to activate one or more intracellular signal transduc-tion pathways that are optimal for a specific gonadotropin subunit gene.
|
Regulation of subunit gene transcription by steroids |
|---|
|
TopAbstractIntroductionPhysiologic changes in subunit...Gonadotropin subunit regulation...Regulation of subunit gene...Regulation of FSHß...References |
|---|
and LHß mRNAs. In contrast, the post-OVX increase in FSHß mRNA was only partially reduced by E2or E2 plus progesterone (P4), reflecting the importance of ovarian inhibin in suppressing FSHß expression (Gharib et al. 1987, Dalkin et al. 1990, 1993); in CAST rats, testosterone either had no effect or enhanced FSHß responses in a dose-dependent manner (Gharib et al. 1987, 1990a, Wierman et al. 1988, 1990, Iliff-Sizemore et al. 1990). Experiments in GDX plus GnRH antagonist-treated rats, to eliminate the effects of steroids on GnRH secretion, largely show that in vivo steroids inhibit both and LHß gene expression by suppressing GnRH. In contrast, the regulation of FSHß by steroids appears to be more complex.
-subunit
In vivo, E2 markedly suppresses -subunit gene transcription. It inhibited the post-OVX increase in -subunit mRNA synthesis (Shupnik et al. 1988), and suppressed the post-OVX or -CAST increases in promoter activity in transgenic mice harboring either a human or bovine promoter-reporter construct (Keri et al. 1991, Hamernik et al. 1992, Clay et al. 1993). However, there is evidence that the suppression of subunit transcription by E2 is largely indirect. Shupnik et al. determined that E2 reduces transcription in vivo largely by suppressing hypothalamic GnRH; E2 had no effect on -subunit mRNA synthesis in rat pituitary cells in vitro (Shupnik et al. 1989a, Shupnik 1996) or in OVX rats treated with GnRH antagonist (Shupnik & Fallest 1994). Additionally, a functional estrogen response element (ERE) in the human promoter has not been identified (Keri et al. 1991), and E2 does not affect human promoter-reporter activity in T3 cells, even in the presence of an exogenous human estrogen-receptor (ER) (Clay et al. 1993). Although it appears that E2 regulates transcription largely via hypothalamic GnRH, it may also have a direct effect on the pituitary. Colin et al.(1996) reported that E2 suppressed basal activity of a human -promoter-LUC construct in the pituitaries of OVX transgenic mice, but enhanced GnRH responsiveness. We and others have also observed that E2 potentiates GnRH stimulation of gene expression, but it is unknown whether the effect is direct or indirect (that is, increasing GnRH receptor numbers) (Mercer et al. 1989, Dalkin et al. 1990, Kerrigan et al. 1993, Turgeon et al. 1996, Kawakami & Winters 1999).
In vivo, progesterone (P4) potentiates the suppressive effects of E2 on -subunit mRNA, largely via decreased GnRH secretion (Simard et al. 1988, Dalkin et al. 1990). The effects of P4 directly on the mRNA in pituitary are mixed; P4 (+E2) reduces OVX, hypothalamically disconnected ewes (Di Gregorio & Nett 1995), and either reduces (Dalkin et al. 1990) or has no effect in the rat (Kerrigan et al. 1993). Little is known about P4 actions on -subunit transcription; however, neither P4 nor P4 the receptor antagonist RU486 modulated E2 ± GnRH-induced changes in human -LUC activity in pituitary cells from transgenic mice (Colin et al. 1996).
Androgens, like estrogens, suppress subunit expression either by reducing hypothalamic GnRH or by direct action on the pituitary. In vivo, testosterone suppressed mRNA and mRNA synthesis rates in male rats even in the presence of GnRH antagonist (Paul et al. 1990). Similarly, testosterone or dihydrotestosterone (DHT) suppressed the post-CAST increases in promoter activity in transgenic mice harboring either a human or bovine promoter-CAT reporter gene (Clay et al. 1993). The human -CAT reporter gene was also repressed by DHT when transiently transfected into T3 cells along with androgen receptor (AR), with suppression requiring both AR and ligand (Clay et al. 1993). A putative androgen response element (ARE) has been identified in the proximal promoter of the human gene between tandem cAMP response elements (CRE) and a CCAAT element (Clay et al. 1993). However, this binding site does not mediate the suppressive effect of androgen on transcription; instead, AR interferes with the proteins that bind an upstream -basal element and the CRE (Heckert et al. 1997). Specifically, AR suppresses promoter activity by protein–protein interactions with the two CRE-binding transcription factors cJun and ATF2 (Jorgensen & Nilson 2001a).
The effects of glucocorticoids on gene expression are inconclusive. In vivo, corticosterone (B) either increases (Ringstrom et al. 1991), decreases (Kilen et al. 1996), or had no effect (McAndrews et al. 1994) on subunit mRNA in rats. In pituitary-derived cell lines, dexamethasone suppressed -subunit mRNA in T3 cells (Akerblom et al. 1990), had no effect on mRNA in LT2 cells (Turgeon et al. 1996) or increased promoter activity in GH3 cells transiently transfected with a human -CAT construct (Gurr & Kourides 1989).
LHß
Estrogens rapidly suppress the post-OVX increases in LHß mRNA synthesis (Shupnik et al. 1988). This reflects a hypothalamic action, as the post-OVX increases in LHß transcription were abolished by a GnRH antagonist (Dalkin et al. 1993, Shupnik & Fallest 1994, Fallest et al. 1995, Burger et al. 2001), and additional treatment with E2 was no more effective than antagonist only (Shupnik & Fallest 1994). However, estrogens also exert direct action on the pituitary, and E2 rapidly increased LHß mRNA synthesis rates in pituitary cells from OVX female rats (Shupnik et al. 1989a, Shupnik 1996), and in pituitary cells from cycling rats, with the greatest effect in cells from rats in proestrus (Shupnik et al. 1989a). Shupnik and coworkers found that ER bound the rat LHß promoter at –1388 to –1105 bp, an area containing a 15 bp imperfect ERE; moreover, promoter-reporter constructs of the rat LHß gene containing the 284 bp estrogen-responsive region, transiently transfected into GH3 cells, were estrogen responsive in an ER-dependent manner (Shupnik et al. 1989b, Shupnik & Rosenzweig 1991). However, the estrogen responsiveness of the LHß promoter may not be conserved across the species. While E2 suppressed LHß promoter activity in OVX transgenic mice harboring a –776 to +10 bp bovine LHß promoter CAT reporter, a high-affinity binding site for the ER was not found in this portion of the promoter (Keri et al. 1994). In addition, E2 had no effect on bovine LHß CAT activity when transiently transfected into LßT2 cells, even when cotransfected with the human ER (Jorgensen & Nilson 2001b). It remains to be determined whether an estrogen-responsive region of the bovine LHß promoter may be more 5' than the area previously investigated. Alternatively, the ER may modulate promoter activity by interacting with other cis-acting elements, as described for androgens on the and LHß promoters.
There is little information on the regulation of LHß gene expression by either P4 or glucocorticoids. Progesterone alone had no effect on LHß mRNA levels in OVX rats and when combined with E2 was no more effective than E2 alone (Dalkin et al. 1990, Kerrigan et al. 1993). Similarly, while E2 blocked bovine LHß CAT promoter activity in OVX transgenic mice, the combination of E2 and P4 was no more effective than E2 alone (McNeilly et al. 1996). In vitro, neither mRNA levels in female P4 nor E2+ P4 altered LHß rat pituitary cells, but P4 alone or in combination with E2 augmented the GnRH-induced increase in LHß mRNA, perhaps by blocking LHß mRNA degradation (Park et al. 1996). Glucocorticoids do not appear to regulate LHß mRNA; B had no effect on LHß mRNA levels in cultured rat pituitary cells (Kilen et al. 1996) and dexamethasone did not alter the activity of the rat LHß promoter (Shupnik & Rosenzweig 1991).
Androgens rapidly suppress the post-CAST rise in LHß transcription. Testosterone inhibited LHß mRNA synthesis in CAST rats (Paul et al. 1990) and suppressed the post-CAST increases in LHß promoter activity in transgenic mice (Keri et al. 1994, Fallest et al. 1995). We examined the effects of testosterone on LHß transcription in vivo; testosterone rapidly suppressed LHß PT below basal values in GnRH-deficient CAST rats (Fig. 11) (Burger et al. 2004). The suppression of LHß PT in GnRH-deficient rats in vivo suggests that testosterone acts directly at the pituitary, but we found no effect of testosterone on LHß PT in cultured rat pituitary cells (Burger et al. 2004). Similarly, DHT had little effect on rat LHß promoter LUC reporter activity in LßT2 cells, but did suppress GnRH-induced LHß promoter activity (Curtin et al. 2001). This action required the AR even though a high-affinity binding site for the AR was not found in this construct. Curtin et al.(2001) determined that the AR suppressed rat LHß promoter activity by protein–protein interactions with the specificity protein-1 (Sp1) transcription factor, and, to a lesser extent, with the early growth response protein (Erg-1), which are required for GnRH stimulation of LHß transcription (Kaiser et al. 2000, Weck et al. 2000). In contrast to the rat, the bovine LHß promoter was directly responsive to testosterone (Jorgensen & Nilson 2001b). The AR, in a ligand-dependent manner, suppressed the activity of bovine LHß CAT when transfected into LßT2 cells. The bovine LHß promoter also lacks an AR binding site, and the AR suppressed bovine LHß transcription by protein–protein interactions with steriodogenic factor 1 (SF-1), blocking its interaction with Pitx1 and the transcriptional initiation complex (Jorgenson & Nilson 2001b).
|
The effects of E2 on FSHß transcription have not been extensively studied, and there appear to be differences among species. In vivo , E2 suppressed the post-OVX increase in FSHß mRNA synthesis in the rat (Shupnik et al. 1988). The site of E2 action in the rat is the hypothalamus, as E2 did not suppress FSHß transcription in OVX rats treated with a GnRH antagonist (Shupnik et al. 1989a) and had no effect on FSHß mRNA synthesis in female rat pituitary fragments (Shupnik & Fallest 1994). In contrast to the rat, E2 suppressed both steady-state FSHß mRNA and mRNA synthesis rates in cultured ovine pituitary cells (Phillips et al. 1988, Baratta et al. 2001), and suppressed the activity of an ovine FSHß promoter-LUC construct trans-fected into ovine pituitary cells (Miller & Miller 1996). The estrogen-responsive region of the ovine FSHß promoter is located at –105 to –84 bp, but does not contain an estrogen-response element or bind ER (Miller & Miller 1996). Instead, this estrogen-responsive region contains two AP-1 sites and is a GnRH enhancer region of the ovine FSHß promoter (Strahl et al. 1998). Although E2 inhibits FSHß transcription in sheep, it had no effect on an ovine FSHß promoter-LUC construct in female transgenic mice, and the authors suggest that mouse gonadotropes lack some factor making them less responsive to negative feedback by estrogen (Huang et al. 2001a). We recently investigated the effects of steroids on FSHß transcription in male rats. Contrary to previous results in females, we PT, but found that E2 markedly suppressed FSHß not FSHß mRNA, and this may suggest that E2 differentially regulates FSHß transcription between the sexes in rodents (Burger et al. 2004).
FSHß transcription is also regulated by P4, and, like estrogens, there appear to be differences between species. Progesterone, in combination with mRNA expression in E2, increased FSHß immature rats (Attardi et al. 1990) and increased the stimulatory effects of GnRH on FSHß mRNA (versus E2 alone) (Kerrigan et al. 1993). Moreover, the preovulatory FSH surge and the accompanying increase in FSHß mRNA can be suppressed by antiprogestins (Ringstrom et al. 1997). Three progesterone-response element (PRE)-like sequences have been identified in the proximal promoter of the rat FSHß gene; these sites bind P4 receptor (PR) and render a heterologous promoter–reporter construct P4 responsive (O’Conner et al. 1997, 1999). In contrast, P4 suppressed endogenous FSHß mRNA synthesis in ovine pituitary cell cultures (Phillips et al. 1988). The ovine FSHß promoter contains six PRE-like sequences that bind PR and render a heterologous promoter reporter construct P4 responsive (Webster et al. 1995). However, contrary to the suppressive effects of P4 on endogenous FSHß transcription, P4 stimulated an ovine FSHß promoter-LUC reporter construct transfected into ovine pituitary cells (Webster et al. 1995).
Glucocorticoids affect FSHß gene expression, and B selectively upregulated FSHß mRNA levels (Ringstrom et al. 1991, McAndrews et al. 1994). These effects are at the level of the gonadotrope, as B or dexamethasone increased FSHß mRNA in rat pituitary cells (Kilen et al. 1996, Bohnsack et al. 2000, Leal et al. 2003) and in rats treated with a GnRH antagonist (McAndrews et al. 1994). Moreover, the effects of B appear to be at the level of transcription, as it increased FSHß mRNA in female rat pituitary cells, without changing post-transcriptional mRNA decay rates (Kilen et al. 1996).
The effects of testosterone on FSHß gene expression in the rat are intriguing. As mentioned previously, testosterone does not suppress the post-GDX increase in FSHß mRNA; instead, it either has no effect or further increases FSHß mRNA expression (Gharib et al. 1987, 1990a, Wierman et al. 1988, 1990, Iliff-Sizemore et al. 1990). Studies in GnRH-deficient rats or in pituitary cell cultures demonstrated that the stimulatory effects of testosterone on FSHß gene expression are at the level of the pituitary (Paul et al. 1990, Wierman & Wang 1990, Dalkin et al. 1992, Winters et al. 1992). Earlier we proposed that testosterone regulated FSHß mRNA stability, since testosterone increased the half-disappearance time of FSHß mRNA from 20 to 50 h, but did not significantly increase FSHß mRNA synthesis (Paul et al. 1990). However, we recently reinvestigated the effects of testosterone on FSHß transcription, and found that it rapidly and specifically increases FSHß PT levels at 3–48 h in male rats (Fig. 11) and that the stimulatory effects on FSHß transcription are androgen specific (Burger et al. 2004). Testosterone also suppresses FS mRNA, which suggests that testosterone’s actions on FSHß transcription may be indirect via activin/FS. Others have reported that the effects of testosterone on FSHß mRNA either require activin (Leal et al. 2003) or are blunted by FS (Bohnsack et al. 2000). To determine whether testosterone stimulation of FSHß PT reflected the fall in pituitary FS, we treated male rat pituitary cells with testosterone with or without exogenous FS. FS alone suppressed FSHß PT, but did not reduce the testosterone-stimulated increase in FSHß PT, suggesting that testosterone increases transcription by direct action on the FSHß gene. Recently, testosterone (or DHT) was reported to increase the activity of an ovine FSHß promoter-reporter transfected into LßT2 cells (Spady et al. 2004). Spady et al.(2004) identified three candidate androgen-response elements (AREs) at –245/–231, –212/–198 and –153/–139 bp of the ovine FSHß promoter, which are the same steroid-binding elements identified by Webster et al.(1995) as PREs. Only the –245/–231 bp putative ARE bound the AR, although mutations in either the –245/–231 or –153/–139 ARE disrupted the stimulation of the promoter by DHT (Spady et al. 2004). In contrast to the rat, the effects of testosterone on the ovine FSHß promoter are activin dependent. The ability of DHT to stimulate the ovine FSHß promoter is abolished by FS treatment, is increased synergistically by activin, and requires an activin-responsive Smad-binding element (SBE) at –138/–124 bp (Spady et al. 2004). Although the AREs identified in the ovine FSHß promoter are well conserved across mammalian species (Spady et al. 2004), the stimulatory effects of testosterone on FSHß expression are not. Testosterone suppressed FSHß mRNA in male rhesus pituitary cells (Kawakami et al. 2002) and a human FSHß promoter construct in transgenic mice (Kumar et al. 1992, Kumar & Low 1993, 1995).
|
Regulation of FSHß gene transcription by activin, FS and inhibin |
|---|
|
TopAbstractIntroductionPhysiologic changes in subunit...Gonadotropin subunit regulation...Regulation of subunit gene...Regulation of FSHß...References |
|---|
The inhibins and activins are members of the transforming growth factor-ß (TGFß) superfamily. The inhibins, heterodimers of an inhibin -subunit and one of two ß-subunits, ßA (inhibin A) or ßB (inhibin B), are produced primarily by the gonads and act in an endocrine manner to suppress pituitary FSH secretion without affecting LH (Burger et al. 1997). The activins are dimers of two inhibin ß-subunits. There are at least four forms of the ß subunit, ßA–ßD, although the ßA and ßB subunits are important in the regulation of FSH. The activins were discovered because of their ability to stimulate FSH synthesis and release it from pituitary cell cultures (Ling et al. 1986, Vale et al. 1986), but it is now known that the activins are produced in a wide variety of tissues and act largely in a paracrine/autocrine manner to regulate functions ranging from development to cellular homeostasis. The pituitary expresses ßB and activin-B (ßBßB) is synthesized and secreted in the pituitary, whereas most other tissues produce activin-A (Meunier et al. 1988). In addition, the activin receptors types I, IIA and IIB are also present in the rat pituitary (Dalkin et al. 1996). FS, a glycoprotein hormone structurally unrelated to the activins and inhibins, binds to and neutralizes the bioactivity of activin. The affinity of FS for activin is high, and the dissociation rate after binding is extremely slow, essentially making the binding event a permanent one (Nakamura et al. 1990). FS was discovered in ovarian follicular fluid by its ability to suppress FSH (Esch et al. 1987), but, like activin, it is also synthesized in a wide array of tissues, including the pituitary gonadotropes and folliculostellate cells (Kogawa et al. 1991a,b, Kaiser et al. 1992). Although FS can be detected in the circulation, its ability to suppress FSH is largely due to paracrine and/or autocrine regulation of bioactive activin at the level of the gonadotrope (for review, see Phillips & de Kretser 1998).
Activin is an important regulator of FSH secretion and FSHß gene expression; it increased FSH secretion and FSHß mRNA in a dose-dependent manner in primary rat pituitary cells (Carroll et al. 1989, Weiss et al. 1993), and increased FSH secretion in vivo (Rivier & Vale 1991, Carrol et al. 1991, Woodruff et al. 1993, Lee & Rivier 1997). The intrapituitary regulation of activin action is important in control of FSHß gene expression; after OVX, pituitary ßB and ActRII mRNAs increase in parallel with FSHß mRNA (Dalkin et al. 1994, 1998, Prendergast et al. 2004), and GnRH pulse frequencies that maximally stimulate FSHß mRNA also stimulate ßB mRNA (Dalkin et al. 1999). Activin increases FSHß mRNA expression by increasing transcription. Activin increased FSHß PT in rat pituitary cells, an effect which could be blocked by the transcription inhibitor actinomycin D (Weiss et al. 1995, Bernard 2004). Activin has also been reported to stimulate ovine, rat and mouse FSHß promoter–reporter constructs (Huang et al. 2001b, Pernasetti et al. 2001, Dupont et al. 2003, Suszko et al. 2003, Bailey et al. 2004, Bernard 2004). In light of these data, recent studies have begun to focus on the mechanism(s) whereby activin signaling regulates promoter activity for the FSHß gene.
Activin signaling requires a series of events, including the activation of intracellular messengers (for review, see Attisano & Wrana 1996, Pangus & Woodruff 2000, Derynck & Zhang 2003). Briefly, activin binds to its type II receptor subunit, either ActRII or IIB, which then pairs with a type I receptor subunit (either ActRI or IB), forming a heteromeric complex at the cell surface. Then serine/threonine kinase activity of the type II subunit phosphorylates the type I subunit, initiating post-receptor signaling/phosphorylation. Although a number of signal cascades may be activated as the result of activin/activin receptor association, the predominant activin-signaling pathway includes the mothers against dpp-related (Smad) proteins.
Eight Smad proteins (Smads 1–8) conduct the intracellular signals for the TGFß super family from receptors to the nucleus (for review, see Derynck & Zhang 2003). For the activin signaling system, receptor-activated Smads2 and 3 are phosphorylated by ActRI and then partner with co-Smad4, which then binds to DNA to regulate gene activity. In pituitary cells, activin-induced increases in FSHß transcription were correlated with increased Smad2 and 3 phosphorylation (Dupont et al. 2003, Bernhard 2004). Additionally, rat or mouse FSHß promoter activity was increased by overexpression of Smad3 and attenuated when Smad2 or 3 protein were suppressed (Dupont et al. 2003, Suszko et al. 2003, Bernhard 2004).
The association of Smad2/3 with Smad4 and the formation of dimers is an important step in signal transduction from the cell surface (Lagna et al. 1996). Smad4 appears essential for activin signaling, as transfection of a constitutively active Smad4 construct alone can induce activin-like effects, whereas cellular expression of Smad2/3 alone does not confer responsiveness (Lagna et al. 1996), and in pituitary cells expression of Smad4 greatly enhances the ability of Smad3 to increase rat FSHß promoter activity (Suszko et al. 2003). Additionally, Smad2/3 activity is regulated by ‘inhibitory’ Smad7, which binds the type I receptor and prevents Smad2/3 phosphorylation. Smad7 gene expression is detected in both normal pituitary cells and gonadotrope cell lines, and overexpression of Smad7 in LßT2 cells disrupted activin-induced increases in FSHß gene expression (Dupont et al. 2003, Bernhard 2004).
To date, data suggest that there is a Smad-binding element (SBE) comprising CAGA- or GTCT-like sequences that are required, but are not sufficient, for Smad binding (Shi & Massague 2003). The affinity of Smads for SBEs is low, and gene activation requires the presence of other cofactors. Some of these transcriptional regulators are specific to the FSHß gene, as recent reports suggest the importance of the nuclear factor Pitx2, a member of the Pitx subfamily of bicoid-related homeodomain factors (Suszko et al. 2003). In that report, critical regions within the rat FSHß promoter were identified for Smad3/4 binding (–281 to –253 bp) and Pitx2 (–230 to –199 bp); more importantly, both Smads and Pitx2 may physically interact in the regulation of the FSHß promoter activation. However, the critical SBE in the rat promoter is conserved only in rodent species. In the ovine FSHß promoter, there are three regions (–973/–962, –167 and –134) required for full activin responsiveness (Bailey et al. 2004). The distal –973/–962 site bound Smad4 protein, and the critical –134 site bound Smad4 in association with the TALE homeodomain proteins Pbx1 and Prep1, and the two proximal activin responsive regions (–167 and –134) are conserved across species and also bind Pbx1 and Prep1 in the mouse gene (Bailey et al. 2004).
Limitation of activin action appears to be an essential component of physiologic gonadotrope function. In addition to the intracellular inhibitor Smad7 described above, the extracellular inhibitors FS and inhibin play key roles in limiting activin action. In the rat pituitary, FS is upregulated by activin, GnRH and PACAP, and is suppressed by testosterone and by FS itself, probably through binding to activin (Simonaka et al. 1991, Kirk et al. 1994, Winters et al. 1997, Burger et al. 2003, 2004). Conversely, in primate pituitary cultures, GnRH is ineffective, and testosterone (as well as activin) increases FS expression (Kawakami et al. 2002). Current thoughts regarding the physiologic role of pituitary-derived FS remain speculative, as a FS-deficient cell model is lacking and knockout of the FS gene is lethal (Matzuk et al. 1995). However, it is widely regarded that pituitary FS influences the FSH response to hypothalamic and gonadal stimuli. FS expression increases after CAST in adult male rats (Kaiser & Chin 1993) and during the reproductive cycle (Halvorson et al. 1994). Additionally, there is a reciprocal relationship over time between FS and FSHß transcription after GnRH pulses; fast-frequency GnRH pulses stimulated FSHß only transiently, and this was followed by an increase in FS mRNA, whereas slow-frequency pulses suppressed FS and increased FSHß, implying that FS attenuates the FSH response (Burger et al. 2002). In male primates, by contrast, FS mRNA is unaffected by CAST, and FSHß mRNA increases by about 50-fold (Winters et al. 2001). Thus, FS appears to function as a brake on FSH production in rodents, but its role in other mammalian species is less certain.
Circulating inhibin is also important in antagonizing the action of activin on pituitary FSH. Serum inhibin levels in the rat are regulated across the estrous cycle and are greatest early in the cycle, peaking at proestrus and declining to their lowest levels at estrus. Low inhibin levels at estrus are coincident with increased FSH secretion, steady-state FSHß mRNA, and FSHß transcription associated with the secondary FSH surge (Shupnik et al. 1989a, Haisenleder et al. 1990, Woodruff et al. 1996). As mentioned previously, after OVX and the loss of circulating inhibin, there is a rapid and GnRH-independent increase in both FSHß mRNA and FSHß PT, which can be mimicked by giving inhibin- antisera to intact rats (Burger et al. 2001). Inhibin administration also decreased ovine FSHß promoter-LUC activity in pituitary cells from transgenic mice and rapidly suppressed FSHß transcription in OVX rats and ewes (Burger et al. 2001, Huang et al. 2001a, Clarke et al. 1993). In addition to suppressing FSHß transcription, inhibin may also regulate the stability of the FSHß mRNA. In rats, inhibin suppressed FSHß mRNA levels with a half-life of 94 min, much shorter than the 40-h half-life of FSHß mRNA in vivo (Burger et al. 2001). In sheep, inhibin suppressed FSHß transcription by only 50% but mRNA levels by 100% (Clarke et al. 1993). Suppression of FSHß mRNA by inhibin in rat pituitary cells could also be blunted by inhibitors of translation, suggesting that inhibin stimulates transcription of a protein that reduces FSHß mRNA stability (Attardi et al. 1991, Attardi & Winters 1993).
The mechanism for the effects of inhibin on FSHß transcription are not clear; the inhibins do bind the activin type II receptors, although with much lower affinity than activin, but this binding does not promote association with the type I receptor, initiate intracellular Smad signaling, or appear to have its own signaling pathway (Mathews & Vale 1991, Attisano et al. 1992, dePaolo 1997), suggesting that inhibin may work as a functional antagonist for activin at the level of the activin receptor. However, in view of inhibin’s low affinity for the type II receptors, this does not explain inhibin action even in the presence of excess activin. Recently, two potential receptors/coreceptors for inhibin have been identified: betaglycan and inhibin-binding protein/p120 (InhBP/p120) (Chong et al. 2000, Lewis et al. 2000). However, new data suggest that betaglycan may be of greater physiologic importance (Chapman et al. 2002). Transfection of COS-7 or HEK293 cells with an expression vector encoding the full-length InhBP/ p120 cDNA (alone or in addition to either of the type II activin receptors) failed to induce specific inhibin binding. In contrast, transfection with constructs containing full-length betaglycan conferred high-affinity inhibin binding with formation of an inhibin/betaglycan/type II activin receptor complex. Furthermore, betaglycan immunoreactivity localizes with gonadotrope cells in the pituitaries of both male and female rats and is correlated with high-serum inhibin, low-serum FSH, and low-pituitary FSHß immunoreactivity just before and after the FSH surge in cycling rats (MacConell et al. 2002, Chapman & Woodruff 2003).
|
Acknowledgements |
|---|
|
References |
|---|
|
TopAbstractIntroductionPhysiologic changes in subunit...Gonadotropin subunit regulation...Regulation of subunit gene...Regulation of FSHß...References |
|---|
Ando H, Hew CL & Urano A 2001 Signal transduction pathways and transcription factors involved in the gonadotropin-releasing hormone-stimulated gonadotropin subunit gene expression. Comparative Biochemistry and Physiology. Part B, Biochemistry and Molecular Biology 129 525–532.
Andrews WV & Conn PM 1986 GnRH stimulates mass changes in phosphoinositides and diacylglycerol accumulation in purified gonadotrope cell cultures. Endocrinology 118 1148–1153.
Attardi B & Fitzgerald T 1990 Effects of progesterone on the estradiol-induced follicle-stimulating hormone (FSH) surge and FSH beta messenger ribonucleic acid in the rat. Endocrinology 126 2281–2287.
Attardi B & Winters SJ 1993 Decay of follicle-stimulating hormone-beta messenger RNA in the presence of transcriptional inhibitors and/or inhibin, activin, or follistatin. Molecular Endocrinology 7 668–680.
Attardi B, Keeping HS, Winters SJ, Kotsuji F & Troen P 1991 Comparison of the effects of cycloheximide and inhibin on the gonadotropin subunit messenger ribonucleic acids. Endocrinology 128 119–125.
Attisano L & Wrana JL 1996 Signal transduction by members of the transforming growth factor-ß superfamily. Cytokine and Growth Factor Reviews 7 327–339.[CrossRef][Medline]
Bäckström CT, McNeilly AC, Leask RM & Baird DT 1982 Pulsatile secretion of LH, FSH, prolactin, oestradiol and progesterone during the human menstrual cycle. Clinical Endocrinology (Oxford) 17 29–42.
Bailey JS, Rave-Harel N, McGillivray SM, Coss D & Mellon PL 2004 Activin regulation of the follicle-stimulating hormone ß-subunit gene involves Smads and the TALE homeodomain proteins Pbx1 and Prep1. Molecular Endocrinology 18 1158–1170.
Baratta M, West LA, Turzillo AM & Nett TM 2001 Activin modulates differential effects of estradiol on synthesis and secretion of follicle-stimulating hormone in ovine pituitary cells. Biology of Reproduction 64 714–719.
Bedecarrats GY & Kaiser UB 2003 Differential regulation of gonadotropin subunit gene promoter activity by pulsatile gonadotropin-releasing hormone (GnRH) in perifused LßT2 cells: role of GnRH receptor concentration. Endocrinology 144 1802–1811.
Ben Menahem D & Naor Z 1994 Regulation of gonadotropin mRNA levels in cultured rat pituitary cells by gonadotropin-releasing hormone (GnRH): role for Ca2+ and protein kinase C. Biochemistry 33 3698–3704.[CrossRef][Medline]
Bernard DJ 2004 Both SMAD2 and SMAD3 Mediate activin-stimulated expression of the follicle-stimulating hormone ß subunit in mouse gonadotrope cells. Molecular Endocrinology 18 606–623.
Bilezikjian LM, Corrigan AZ, Blount AL, Chen Y & Vale WW 2001 Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells. Endocrinology 142 1065–1072.
Bohnsack BL, Szabo M, Kilen SM, Tam DH & Schwartz NB 2000 Follistatin suppresses steroid-enhanced follicle-stimulating hormone release in vitro in rats. Biology of Reproduction 62 636–641.
Bourne GA 1988 cAMP indirectly mediates the extracellular calcium independent release of LH. Molecular and Cellular Endocrinology 58 155–160.[CrossRef][Web of Science][Medline]
Burger HG & Robertson DM 1997 Editorial: inhibin in the male –progress at last. Endocrinology 138 1361–1362.
Burger LL, Dalkin AC, Aylor KW, Workman LJ, Haisenleder DJ & Marshall JC 2001 Regulation of gonadotropin subunit transcription after ovariectomy in the rat: measurement of subunit primary transcripts reveals differential roles of GnRH and inhibin. Endocrinology 142 3435–3442.
Burger LL, Dalkin AC, Aylor KW, Haisenleder DJ & Marshall JC 2002 GnRH pulse frequency modulation of gonadotropin subunit gene transcription in normal gonadotropes – assessment by primary transcript assay provides evidence for roles of GnRH and follistatin. Endocrinology 143 3243–3249.
Burger LL, Haisenleder DJ, Aylor KW, Dalkin AC, Prendergast KA & Marshall JC 2004 Regulation of luteinizing hormone-ß and follicle-stimulating hormone (FSH)- ß gene transcription by androgens: testosterone directly stimulates FSH-ß transcription independent from its role on follistatin gene expression. Endocrinology 145 71–78.
Carroll RS, Corrigan AZ, Gharib SD, Vale W & Chin WW 1989 Inhibin, activin, and follistatin: regulation of follicle-stimulating hormone messenger ribonucleic acid levels. Molecular Endocrinology 3 1969–1976.
Carroll RS, Kowash PM, Lofgren JA, Schwall RH & Chin WW 1991 In vivo regulation of FSH synthesis by inhibin and activin. Endocrinology 129 3299–3304.
Chapman SC & Woodruff TK 2003 Betaglycan localization in the female rat pituitary: implications for the regulation of follicle-stimulating hormone by inhibin. Endocrinology 144 5640–5649.
Chapman SC, Bernard DJ, Jelen J & Woodruff TK 2002 Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Molecular and Cellular Endocrinology 196 79–93.[CrossRef][Web of Science][Medline]
Chen X, Rubock MJ & Whitman M 1996 A transcriptional partner for MAD proteins in TGF-ß signaling. Nature 383 691–696.[CrossRef][Medline]
Chen Y, Bhushan A & Vale W 1997 Smad 8 mediates the signaling of the receptor serine kinase. PNAS 94 12938–12943.
Chin WW 1987 Glycoprotein hormone genes. In Genes Encoding Hormones and Regulated Peptides, pp 137–149. Ed. JF Habener. Clifton, NJ: Humana Press.
Chong H, Pangas SA, Bernard DJ, Wang E, Gitch J, Chen W, Draper LB, Cox ET & Woodruff TK 2000 Structure and expression of a membrane component of the inhibin receptor system. Endocrinology 141 2600–2607.
Clarke IJ & Cummins JT 1982 The temporal relationship between gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes. Endocrinology 111 1737–1739.
Clarke IJ, Rao A, Fallest PC & Shupnik MA 1993 Transcription rate of the follicle stimulating hormone (FSH) beta subunit gene is reduced by inhibin in sheep but this does not fully explain the decrease in mRNA. Molecular and Cellular Endocrinology 91 211–216.[CrossRef][Web of Science][Medline]
Clay CM, Keri RA, Finicle AB, Heckert LL, Hamernik DL, Marschke KM, Wilson EM, French FS & Nilson JH 1993 Transcriptional repression of the glycoprotein hormone alpha subunit gene by androgen may involve direct binding of androgen receptor to the proximal promoter. Journal of Biological Chemistry 268 13556–13564.
Colin IM, Bauer-Dantoin AC, Sundaresan S, Kopp P & Jameson JL 1996 Sexually dimorphic transcriptional responses to gonadotropin-releasing hormone require chronic in vivo exposure to estradiol. Endocrinology 137 2300–2307.[Abstract]
Cui ZJ, Gorelick FS & Dannies PS 1994 Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine. Endocrinology 134 2245–2250.[Abstract]
Cui ZJ, Hidaka H & Dannies PS 1996 KN-62, a calcium/ calmodulin-dependent protein kinase II inhibitor, inhibits high potassium-stimulated prolactin secretion and intracellular calcium increases in anterior pituitary cells. Biochimica et Biophysica Acta 1310 343–347.[Medline]
Curtin D, Jenkins S, Farmer N, Anderson AC, Haisenleder DJ, Rissman E, Wilson EM & Shupnik MA 2001 Androgen suppression of GnRH-stimulated rat LHbeta gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region. Molecular Endocrinology 15 1906–1917.
Dalkin AC, Haisenleder DJ, Ortolano GA, Ellis TR & Marshall JC 1989 The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression. Endocrinology 125 917–924.
Dalkin AC, Haisenleder DJ, Ortolano GA, Suhr A & Marshall JC 1990 Gonadal regulation of gonadotropin subunit gene expression: evidence for regulation of follicle-stimulating hormone-beta messenger ribonucleic acid by nonsteroidal hormones in female rats. Endocrinology 127 798–806.
Dalkin AC, Paul SJ, Haisenleder DJ, Ortolano GA, Yasin M & Marshall JC 1992 Gonadal steroids effect similar regulation of gonadotrophin subunit mRNA expression in both male and female rats. Journal of Endocrinology 132 39–45.
Dalkin AC, Knight CD, Shupnik MA, Haisenleder DJ, Aloi J, Kirk SE, Yasin M & Marshall JC 1993 Ovariectomy and inhibin immunoneutralization acutely increase follicle-stimulating hormone-beta messenger ribonucleic acid concentrations: evidence for a nontranscriptional mechanism. Endocrinology 132 1297–1304.
Dalkin AC, Haisenleder DJ, Yasin M, Gilrain JT & Marshall JC 1996 Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin. Endocrinology 137 548–554.[Abstract]
Dalkin AC, Haisenleder DJ, Gilrain JT, Aylor K, Yasin M & Marshall JC 1998 Regulation of pituitary follistatin and inhibin/activin subunit messenger ribonucleic acids (mRNAs) in male and female rats: evidence for inhibin regulation of follistatin mRNA in females. Endocrinology 139 2818–2823.
Dalkin AC, Haisenleder DJ, Gilrain JT, Aylor K, Yasin M & Marshall JC 1999 Gonadotropin-releasing hormone regulation of gonadotropin subunit gene expression in female rats: actions on follicle-stimulating hormone beta messenger ribonucleic acid (mRNA) involve differential expression of pituitary activin (beta-B) and follistatin mRNAs. Endocrinology 140 903–908.
Dalkin AC, Burger LL, Aylor KW, Haisenleder DJ, Workman LJ, Cho S & Marshall JC 2001 Regulation of gonadotropin subunit gene transcription by gonadotropin-releasing hormone: measurement of primary transcript ribonucleic acids by quantitative reverse transcription-polymerase chain reaction assays. Endocrinology 142 139–146.
De Koninck P & Schulman H 1998 Sensitivity of CaM kinase II to the frequency of calcium oscillations. Science 279 227–230.
Delegeane AM, Ferland LH & Mellon PL 1987 Tissue specific enhancer of human glycoprotein hormone alpha-subunit gene: dependence on cAMP-inducible elements. Molecular and Cellular Biology 7 3994–4002.
DePaolo LV 1997 Inhibins, activins, and follistatins: the saga continues. Proceedings of the Society for Experimental Biology and Medicine 214 328–339.[CrossRef][Medline]
Derynck R & Zhang YE 2003 Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 577–584.[CrossRef][Medline]
Di Gregorio GB & Nett TM 1995 Estradiol and progesterone influence the synthesis of gonadotropins in the absence of gonadotropin-releasing hormone in the ewe. Biology of Reproduction 53 166–172.[Abstract]
Dolmetsch RE, Lewis RS, Goodnow CC & Healy JI 1997 Differential activation of transcriptional factors induced by calcium response amplitude and duration. Nature 386 855–858.[CrossRef][Medline]
Duan WR, Shin JL & Jameson JL 1999 Estradiol suppresses phosphorylation of cAMP response element binding protein (CREB) in the pituitary: evidence for indirect action via GnRH. Molecular Endocrinology 13 1338–1352.
Dupont J, McNeilly J, Vaiman A, Canepa S, Combarnous Y & Taragnat C 2003 Activin signaling pathways in ovine pituitary and LßT2 gonadotrope cells. Biology of Reproduction 68 1877–1887.
Durham PL & Russo AF 2000 Differential regulation of MAPK-responsive genes by duration of a calcium signal. Molecular Endocrinology 14 1570–1582.
Ellsworth BS, White BR, Burns AT, Cherrington BD, Otis AM & Clay CM 2003 c-Jun N-terminal kinase activation of activator protein-1 underlies homologous regulation of the gonadotropin-releasing hormone receptor gene in alpha T3–1 cells. Endocrinology 144 839–849.
Esch FS, Shimasaki S, Mercado M, Cooksey K, Ling N, Ying S, Ueno N & Guillemin R 1987 Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Molecular Endocrinology 1 849–855.
Fallest PC, Trader GL, Darrow JM & Shupnik MA 1995 Regulation of rat luteinizing hormone beta gene expression in transgenic mice by steroids and a gonadotropin-releasing hormone antagonist. Biology of Reproduction 53 103–109.[Abstract]
Fowkes RC, King P & Burrin JM 2002 Regulation of human glycoprotein hormone alpha-subunit gene transcription in LßT2 gonadotropes by protein kinase C and extracellular signal-regulated kinase 1/2. Biology of Reproduction 67 725–734.
Garrel G, McArdle CA, Hemmings BA & Counis R 1997 Gonadotropin-releasing hormone and pituitary adenylate cyclase-activating polypeptide affect levels of cyclic adenosine 3',5'- monophosphate-dependent protein kinase A (PKA) subunits in the clonal gonadotrope alphaT3–1 cells: evidence for cross-talk between PKA and protein kinase C pathways. Endocrinology 138 2259–2266.
Gharib SD, Wierman ME, Badger TM & Chin WW 1987 Sex steroid hormone regulation of follicle-stimulating hormone subunit messenger ribonucleic acid (mRNA) levels in the rat. Journal of Clinical Investigation 80 294–299.
Gharib SD, Leung PC, Carroll RS & Chin WW 1990a Androgens positively regulate follicle-stimulating hormone beta-subunit mRNA levels in rat pituitary cells. Molecular Endocrinology 4 1620–1626.
Gharib SD, Wierman ME, Shupnik MA & Chin WW 1990b Molecular biology of the pituitary gonadotropins. Endocrine Reviews 11 177–199.
Gu X & Spitzer NC 1995 Distinct aspects of neuronal differentiation encoded by frequency of spontaneous calcium transients. Nature 375 784–787.[CrossRef][Medline]
Gurr JA & Kourides IA 1989 Regulation of the transfected human glycoprotein hormone alpha-subunit gene by dexamethasone and thyroid hormone. DNA 8 473–480.[Web of Science][Medline]
Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH & Kern SE 1996 DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271 350–353.[Abstract]
Haisenleder DJ, Katt JA, Ortolano GA, el-Gewely MR, Duncan JA, Dee C & Marshall JC 1988 Influence of gonadotropin-releasing hormone pulse amplitude, frequency, and treatment duration on the regulation of luteinizing hormone (LH) subunit messenger ribonucleic acids and LH secretion. Molecular Endocrinology 2 338–343.
Haisenleder DJ, Ortolano GA, Jolly D, Dalkin AC, Landefeld TD & Vale WW, Marshall JC 1990 Inhibin secretion during the rat estrous cycle: relationships to FSH secretion and FSH beta subunit mRNA concentrations. Life Sciences 47 1769–1773.[CrossRef][Web of Science][Medline]
Haisenleder DJ, Dalkin AC, Ortolano GA, Marshall JC & Shupnik MA 1991 A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo. Endocrinology 128 509–517.
Haisenleder DJ, Yasin M & Marshall JC 1992 Enhanced effectiveness of pulsatile 3',5'-cyclic adenosine monophosphate in stimulating prolactin and alpha-subunit gene expression. Endocrinology 131 3027–3033.
Haisenleder DJ, Ortolano GA, Yasin M, Dalkin AC & Marshall JC 1993a Regulation of gonadotropin subunit messenger ribonucleic acid expression by gonadotropin-releasing hormone pulse amplitude in vitro. Endocrinology 132 1292–1296.
Haisenleder DJ, Yasin M & Marshall JC 1993b The regulation of prolactin, thyrotropin and gonadotropin subunit gene expression by pulsatile or continuous calcium signals. Endocrinology 133 2055–2061.
Haisenleder DJ, Yasin M & Marshall JC 1995 Regulation of gonadotropin, thyrotropin subunit and prolactin mRNAs by pulsatile or continuous PKC stimulation. Endocrinology 136 13–19.[Abstract]
Haisenleder DJ, Yasin M & Marshall JC 1997 Gonadotropin subunit and gonadotropin-releasing hormone receptor gene expression are regulated by alterations in the frequency of calcium pulsatile signals. Endocrinology 138 5227–5230.
Haisenleder DJ, Cox ME, Parsons SJ & Marshall JC 1998 Gonadotropin-releasing hormone pulses are required to maintain activation of mitogen-activated protein kinase: role in stimulation of gonadotrope gene expression. Endocrinology 139 3104–3111.
Haisenleder DJ, Workman LJ, Burger LL, Aylor KW, Dalkin AC & Marshall JC 2001 Gonadotropin subunit transcriptional responses to calcium signals in the rat: evidence for regulation by pulse frequency. Biology of Reproduction 65 1789–1793.
Haisenleder DJ, Burger LL, Aylor KW, Dalkin AC & Marshall JC 2003a GnRH stimulation of gonadotropin subunit transcription: evidence for the involvement of calcium/calmodulin-dependent protein kinase type II (Ca/CAMK II) activation in rat pituitaries. Endocrinology 144 2768–2774.[CrossRef][Web of Science][Medline]
Haisenleder DJ, Ferris HA & Shupnik MA 2003b The calcium component of GnRH-stimulated LH subunit gene transcription is mediated by calcium/calmodulin-dependent protein kinase type II (Ca/CAMK II). Endocrinology 144 2409–2416.
Halvorson LM, Weiss J, Bauer-Dantoin AC & Jameson JL 1994 Dynamic regulation of pituitary follistatin messenger ribonucleic acids during the rat estrous cycle. Endocrinology 134 1247–1253.
Halvorson LM, Kaiser UB & Chin WW 1999 The protein kinase C system acts through the early growth response protein 1 to increase LHbeta gene expression in synergy with steroidogenic factor-1. Molecular Endocrinology 13 106–116.
Ham J, Jiang Z, Kravchenko VV & Ulevitch RJ 1997 Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386 296–299.[CrossRef][Medline]
Hamernik DL, Keri RA, Clay CM, Clay JN, Sherman GB, Sawyer HR Jr, Nett TM & Nilson JH 1992 Gonadotrope- and thyrotrope-specific expression of the human and bovine glycoprotein hormone alpha-subunit genes is regulated by distinct cis-acting elements. Molecular Endocrinology 6 1745–1755.
Han XB & Conn PM 1999 The role of PKA and PKC pathways in the regulation of MAPK activation in response to GnRH receptor activation. Endocrinology 140 2241–2251.
Hanson PI & Schulman H 1992 Neuronal Ca2+/calmodulin-dependent protein kinases. Annual Review of Biochemistry 61 559–601.[CrossRef][Web of Science][Medline]
Heckert LL, Wilson EM & Nilson JH 1997 Transcriptional repression of the alpha-subunit gene by androgen receptor occurs independently of DNA binding but requires the DNA-binding and ligand-binding domains of the receptor. Molecular Endocrinology 11 1497–1506.
Holl RW, Thorner MO, Mandell GL, Sullivan JA , Sinha YN & Leong DA 1988 Spontaneous oscillations of intracellular calcium and GH secretion. Journal of Biological Chemistry 263 9682–9685.
Hsieh KP & Martin TF 1992 Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11. Molecular Endocrinology 6 1673–1681.
Huang HJ, Sebastian J, Strahl BD, Wu JC & Miller WL 2001a The promoter for the ovine follicle-stimulating hormone-beta gene (FSHbeta) confers FSHbeta-like expression on luciferase in transgenic mice: regulatory studies in vivo and in vitro. Endocrinology 142 2260–2266.
Huang HJ, Sebastian J, Strahl BD, Wu JC & Miller WL 2001b Transcriptional regulation of the ovine follicle-stimulating hormone-beta gene by activin and gonadotropin-releasing hormone (GnRH): involvement of two proximal activator protein-1 sites for GnRH stimulation. Endocrinology 142 2267–2274.
Iliff-Sizemore SA, Ortolano GA, Haisenleder DJ, Dalkin AC, Krueger KA & Marshall JC 1990 Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude. Endocrinology 127 2876–2883.
Jorgensen JS & Nilson JH 2001a AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein–protein interactions with cJun and activation transcription factor 2. Molecular Endocrinology 15 1496–1504.
Jorgensen JS & Nilson JH 2001b AR suppresses transcription of the LHß subunit by interacting with steroidogenic factor-1. Molecular Endocrinology 15 1505–1516.
Kaiser UB, Lee BL, Carroll RS, Unabia G, Chin WW & Childs GV 1992 Follistatin gene expression in the pituitary: localization in gonadotropes and folliculostellate cells in diestrous rats. Endocrinology 130 3048–3056.
Kaiser UB & Chin WW 1993 Regulation of follistatin messenger ribonucleic acid levels in the rat pituitary. Journal of Clinical Investigation 91 2523–2531.
Kaiser UB, Conn PM & Chin WW 1997a Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocrine Reviews 18 46–70.
Kaiser UB, Jakubowiak A, Steinberger A & Chin WW 1997b Differential effects of gonadotropin-releasing hormone (GnRH) pulse frequency on gonadotropin subunit and GnRH receptor messenger ribonucleic acid levels in vitro. Endocrinology 138 1224–1231.
Kaiser UB, Halvorson LM & Chen MT 2000 Sp1, steroidogenic factor 1 (SF-1), and early growth response protein 1 (egr-1) binding sites form a tripartite gonadotropin-releasing hormone response element in the rat luteinizing hormone-beta gene promoter: an integral role for SF-1. Molecular Endocrinology 14 1235–1245.
Kato Y, Tomizawa K & Kato T 1999 Multiple binding sites for nuclear proteins of the anterior pituitary located in the 5'-flanking region of the porcine FSH beta subunit gene. Molecular and Cellular Endocrinology 158 69–78.[CrossRef][Web of Science][Medline]
Kawabata M, Imamura T, Inoue H, Hanai J, Nishihara A, Hanyu A, Takase M, Ishidou Y, Udagawa Y, Oeda E, Goto D, Yagi K, Kato M & Miyazono K 1999 Intracellular signaling of the TGF-beta superfamily by Smad proteins. Annals of the New York Academy of Sciences 886 73–82.[CrossRef][Web of Science][Medline]
Kawakami S & Winters SJ 1999 Regulation of luteinizing hormone secretion and subunit messenger ribonucleic acid expression by gonadal steroids in perifused pituitary cells from male monkeys and rats. Endocrinology 140 3587–3593.
Kawakami S, Fujii Y, Okada Y & Winters SJ 2002 Paracrine regulation of FSH by follistatin in folliculostellate cell-enriched primate pituitary cell cultures. Endocrinology 143 2250–2258.
Keri RA, Andersen B, Kennedy GC, Hamernik DL, Clay CM, Brace AD, Nett TM, Notides AC & Nilson JH 1991 Estradiol inhibits transcription of the human glycoprotein hormone alpha-subunit gene despite the absence of a high affinity binding site for estrogen receptor. Molecular Endocrinology 5 725–733.
Keri RA, Wolfe MW, Saunders TL, Anderson I, Kendall SK, Wagner T, Yeung J, Gorski J, Nett TM, Camper SA & Nilson JH 1994 The proximal promoter of the bovine luteinizing hormone beta-subunit gene confers gonadotrope-specific expression and regulation by gonadotropin-releasing hormone, testosterone, and 17 ß-estradiol in transgenic mice. Molecular Endocrinology 8 1807–1816.
Kerrigan JR, Dalkin AC, Haisenleder DJ, Yasin M & Marshall JC 1993 Failure of gonadotropin-releasing hormone (GnRH) pulses to increase luteinizing hormone beta messenger ribonucleic acid in GnRH-deficient female rats. Endocrinology 133 2071–2079.
Kerrigan JR, Yasin M, Haisenleder DJ, Dalkin AC & Marshall JC 1995 Regulation of gonadotropin subunit messenger ribonucleic acid expression in gonadotropin-releasing hormone (GnRH)-deficient female rats: effects of GnRH, galanin, GnRH-associated peptide, neuropeptide-Y, and thyrotropin-releasing hormone. Biology of Reproduction 53 1–7.[Abstract]
Kilen SM, Szabo M, Strasser GA, McAndrews JM, Ringstrom SJ & Schwartz NB 1996 Corticosterone selectively increases follicle-stimulating hormone beta-subunit messenger ribonucleic acid in primary anterior pituitary cell culture without affecting its half-life. Endocrinology 137 3802–3807.[Abstract]
Kirk SE, Dalkin AC, Yasin M, Haisenleder DJ & Marshall JC 1994 Gonadotropin-releasing hormone pulse frequency regulates expression of pituitary follistatin messenger ribonucleic acid: a mechanism for differential gonadotrope function. Endocrinology 135 876–880.[Abstract]
Kogawa K, Nakamura T, Sugino K, Takio K, Titani K & Sugino H 1991a Activin-binding protein is present in pituitary. Endocrinology 128 1434–1440.
Kogawa K, Ogawa K, Hayashi Y, Nakamura T, Titani K & Sugino H 1991b Immunohistochemical localization of follistatin in rat tissues. Endocrinologia Japonica 38 383–391.[Medline]
Kumar TR & Low MJ 1993 Gonadal steroid hormone regulation of human and mouse follicle stimulating hormone beta-subunit gene expression in vivo. Molecular Endocrinology 7 898–906.
Kumar TR & Low MJ 1995 Hormonal regulation of human follicle-stimulating hormone-beta subunit gene expression: GnRH stimulation and GnRH-independent androgen inhibition. Neuroendocrinology 61 628–637.[Web of Science][Medline]
Kumar TR, Fairchild-Huntress V & Low MJ 1992 Gonadotrope-specific expression of the human follicle-stimulating hormone beta-subunit gene in pituitaries of transgenic mice. Molecular Endocrinology 6 81–90.
Lagna G, Hata A, Hemmati-Brivanlou A & Massague J 1996 Partnership between DPC4 and SMAD proteins in TGF-ß signaling pathways. Nature 383 832–836.[CrossRef][Medline]
Leal AM, Blount AL, Donaldson CJ, Bilezikjian LM & Vale WW 2003 Regulation of follicle-stimulating hormone secretion by the interactions of activin-A, dexamethasone and testosterone in anterior pituitary cell cultures of male rats. Neuroendocrinology 77 298–304.[CrossRef][Web of Science][Medline]
Lee S & Rivier C 1997 Effect of repeated activin-A treatment on the activity of the hypothalamic-pituitary-gonadal axis of the adult male rat. Biology of Reproduction 56 969–975.[Abstract]
Levi NL, Hanoch T, Benard O, Rozenblat M, Harris D, Reiss N, Naor Z & Seger R 1998 Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3–1 cell line is mediated by protein kinase C, c-Src, and CDC42. Molecular Endocrinology 12 815–824.
Levine JE & Duffy MT 1988 Simultaneous measurement of luteinizing hormone (LH)-releasing hormone, LH, and follicle-stimulating hormone release in intact and short-term castrate rats. Endocrinology 122 2211–2221.
Levine JE & Ramirez VD 1982 Luteinizing hormone-releasing hormone release during the rat estrous cycle and after ovariectomy, as estimated with push-pull cannulae. Endocrinology 111 1439–1448.
Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM & Vale W 2000 Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404 411–414.[CrossRef][Medline]
Lin X & Conn PM 1999 Transcriptional activation of GnRH receptor gene by GnRH: involvement of multiple signal transduction pathways. Endocrinology 140 358–364.
Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M & Guillemin R 1986 A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone. Biochemical and Biophysical Research Communications 138 1129–1137.[CrossRef][Web of Science][Medline]
Liu F, Austin DA, Mellon PL, Olefsky JM & Webster NJ 2002a GnRH activates ERK1/2 leading to the induction of c-fos and LHbeta protein expression in LßT2 cells. Molecular Endocrinology 16 419–434.
Liu F, Usui I, Evans LG, Austin DA, Mellon PL, Olefsky JM & Webster NJ 2002b Involvement of Both Gq/11 and Gs Proteins in gonadotropin-releasing hormone receptor-mediated signaling in LßT2 cells. Journal of Biological Chemistry s277 32099–32108.
MacConell LA, Leal AM & Vale WW 2002 The distribution of betaglycan protein and mRNA in rat brain, pituitary, and gonads: implications for a role for betaglycan in inhibin-mediated reproductive functions. Endocrinology 143 1066–1075.
Marshall JC & Kelch RP 1986 GnRH: role of pulsatile secretion in the regulation of reproduction. New England Journal of Medicine 315 1459–1468.[Web of Science][Medline]
Mather JP, Moore A & Li RH 1997 Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proceedings of the Society for Experimental Biology and Medicine 215 209–222.[CrossRef][Medline]
Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR & Bradley A 1995 Multiple defects and perinatal death in mice deficient in follistatin. Nature 374 360–363.[CrossRef][Medline]
Maurer RA, Kim KE, Schoderbek WE, Roberson MS & Glenn DJ 1999 Regulation of glycoprotein hormone alpha-subunit gene expression. Recent Progress in Hormone Research 54 455–484.
McAndrews JM, Ringstrom SJ, Dahl KD & Schwartz NB 1994 Corticosterone in vivo increases pituitary follicle-stimulating hormone (FSH)-beta messenger ribonucleic acid content and serum FSH bioactivity selectively in female rats. Endocrinology 134 158–163.
McDowell N & Gurdon JB 1999 Activin as a morphogen in Xenopus mesoderm. Seminars in Cell and Developmental Biology 10 311–317.
McNeilly JR, Brown P, Mullins J, Clark AJ & McNeilly AS 1996 Characterization of the ovine LH beta-subunit gene: the promoter is regulated by GnRH and gonadal steroids in transgenic mice. Journal of Endocrinology 151 481–489.
Mercer JE, Clements JA, Funder JW & Clarke IJ 1989 Regulation of follicle-stimulating hormone beta and common alpha-subunit messenger ribonucleic acid by gonadotropin-releasing hormone and estrogen in the sheep pituitary. Neuroendocrinology 50 321–326.[CrossRef][Web of Science][Medline]
Meunier H, Rivier C, Evans RM & Vale W 1988 Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. PNAS 85 247–251.
Miller CD & Miller WL 1996 Transcriptional repression of the ovine follicle-stimulating hormone-beta gene by 17 beta-estradiol. Endocrinology 137 3437–3446.[Abstract]
Miller SG & Kennedy MB 1986 Regulation of brain type II Ca2+/calmodulin-dependent protein kinase by autophosphorylation: a Ca2+-triggered molecular switch. Cell 44 861–870.[CrossRef][Web of Science][Medline]
Mitchell R, Sim PJ, Leslie T, Johnson MS & Thomson FJ 1994 Activation of MAP kinase associated with the priming effect of LHRH. Journal of Endocrinology 140 R15–R18.
Mulvaney JM, Zang T, Fewtrell C & Roberson MS 1999 Calcium influx through L-type channels is required for selective activation of extracellular signal-regulated kinase by GnRH. Journal of Biological Chemistry 274 29796–29804.
Munz B, Tretter YP, Hertel M, Engelhardt F, Alzheimer C & Werner S 2001 The roles of activins in repair processes of the skin and the brain. Molecular and Cellular Endocrinology 180 169–177.[CrossRef][Web of Science][Medline]
Nakamura T, Takio K, Eto Y, Shibai H, Titani K & Sugino H 1990 Activin-binding protein from rat ovary is follistatin. Science 247 836–838.
Naor Z 1990 Signal transduction mechanisms of Ca2+ mobilizing hormones: the case of gonadotropin-releasing hormone. Endocrine Reviews 11 326–353.
Neill JD 2002 Minireview: GnRH and GnRH receptor genes in the human genome. Endocrinology 143 737–743.
Norwitz ER, Cardona GR, Jeong KH & Chin WW 1999 Identification and characterization of the gonadotropin-releasing hormone response elements in the mouse gonadotropin-releasing hormone receptor gene. Journal of Biological Chemistry 274 867–880.
Nowakowski BE, Okimura Y & Maurer RA 1997 Characterization of DNA regions mediating the ability of Ca2+/calmodulin dependent protein kinase II to stimulate prolactin promoter activity. Molecular and Cellular Endocrinology 132 109–116.[CrossRef][Web of Science][Medline]
O’Conner JL, Wade MF, Edwards DP & Mahesh VB 1999 Progesterone and regulation of the follicle-stimulating hormone (FSH-beta) gene. Steroids 64 592–597.[CrossRef][Web of Science][Medline]
O’Conner JL, Wade MF, Prendergast P, Edwards DP, Boonyaratanakornkit V & Mahesh VB 1997 A 361 base pair region of the rat FSH-beta promoter contains multiple progesterone receptor-binding sequences and confers progesterone responsiveness. Molecular and Cellular Endocrinology 136 67–78.[CrossRef][Web of Science][Medline]
Ortolano GA, Haisenleder DJ, Dalkin AC, Iliff-Sizemore SA, Landefeld TD, Maurer RA & Marshall JC 1988 Follicle-stimulating hormone beta subunit messenger ribonucleic acid concentrations during the rat estrous cycle. Endocrinology 123 2946–2948.
Pangus SA & Woodruff TK 2000 Activin signal transduction pathways. Trends in Endocrinology and Metabolism 11 309–314.[CrossRef][Web of Science][Medline]
Papavasiliou SS, Zmeili S, Herbon L, Duncan-Weldon J, Marshall JC & Landefeld TD 1986 Alpha and luteinizing hormone beta messenger ribonucleic acid (RNA) of male and female rats after castration: quantitation using an optimized RNA dot blot hybridization assay. Endocrinology 119 691–698.
Park D, Cheon M, Kim C, Kim K & Ryu K 1996 Progesterone together with estradiol promotes luteinizing hormone beta-subunit mRNA stability in rat pituitary cells cultured in vitro. European Journal of Endocrinology 134 236–242.
Paul SJ, Ortolano GA, Haisenleder DJ, Stewart JM, Shupnik MA & Marshall JC 1990 Gonadotropin subunit messenger RNA concentrations after blockade of gonadotropin-releasing hormone action: testosterone selectively increases follicle-stimulating hormone beta-subunit messenger RNA by posttranscriptional mechanisms. Molecular Endocrinology 4 1943–1955.
Pernasetti F, Vasilyev VV, Rosenberg SB, Bailey JS, Huang HJ, Miller WL & Mellon PL 2001 Cell-specific transcriptional regulation of follicle-stimulating hormone-beta by activin and gonadotropin-releasing hormone in the LßT2 pituitary gonadotrope cell model. Endocrinology 142 2284–2295.
Phillips CL, Lin LW, Wu JC, Guzman K, Milsted A & Miller WL 1988 17 Beta-estradiol and progesterone inhibit transcription of the genes encoding the subunits of ovine follicle-stimulating hormone. Molecular 2 641–649.
Phillips DJ, Jones KL, Scheerlinck JY, Hedger MP & de Kretser DM 2001 Evidence for activin A and follistatin involvement in the systemic inflammatory response. Molecular and Cellular Endocrinology 180 155–162.[CrossRef][Web of Science][Medline]
Plendl J 2000 Angiogenesis and vascular regression in the ovary. Anatomia, Histologia, Embryologia: Veterinary Medicine Series C 29 257–266.
Prendergast KA, Burger LL, Aylor KW, Haisenleder DJ, Dalkin AC & Marshall JC 2003 Pituitary follistatin gene expression in female rats: evidence that inhibin regulates transcription. Biology of Reproduction 70 364–370.
Quirk CC, Lozada KL, Keri RA & Nilson JH 2001 A single Pitx1 binding site is essential for activity of the LHß promoter in transgenic mice. Molecular Endocrinology 15 734–746.
Reiss N, Llevi LN, Shacham S, Harris D, Seger R & Naor Z 1997 Mechanism of MAPK activation by GnRH in the pituitary alpha T-3 cell line: differential roles of calcium and PKC. Endocrinology 138 1673–1682.
Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JK, Markowitz SD, Kinzler KW & Vogelstein B 1996 MAD-related genes in the human. Nature Genetics 13 347–349.[CrossRef][Web of Science][Medline]
Ringstrom SJ, McAndrews JM, Rahal JO & Schwartz NB 1991 Cortisol in vivo increases FSH beta mRNA selectively in pituitaries of male rats. Endocrinology 129 2793–2795.
Ringstrom SJ, Szabo M, Kilen SM, Saberi S, Knox KL & Schwartz NB 1997 The antiprogestins RU486 and ZK98299 affect follicle-stimulating hormone secretion differentially on estrus, but not on proestrus. Endocrinology 138 2286–2290.
Rivier C, Schwall R, Mason A, Burton L & Vale W 1991 Effect of recombinant inhibin on gonadotropin secretion during proestrus and estrus in the rat. Endocrinology 128 2223–2228.
Roberson MS, Misra-Press A, Laurance ME, Stork PJS & Maurer RA 1995 A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone -subunit promoter by GnRH. Molecular and Cellular Biology 15 3531–3539.[Abstract]
Roberson MS, Zhang T, Li HL & Mulvaney JM 1999 Activation of the p38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone. Endocrinology 140 1310–1318.
Roberts V, Meunier H, Vaughan J, Rivier J, Rivier C, Vale W & Sawchenko P 1989 Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology 124 552–554.
Salton SRJ, Blum M, Jonassen JA, Clayton RN & Roberts JL 1988 Stimulation of pituitary luteinizing hormone secretion by gonadotropin-releasing hormone is not coupled to ß-luteinizing hormone gene transcription. Molecular Endocrinology 2 1033–1042.
Saunders BD, Sabbagh E, Chin WW & Kaiser UB 1998 Differential use of signal transduction pathways in the gonadotropin-releasing hormone-mediated regulation of gonadotropin subunit gene expression. Endocrinology 139 1835–1843.
Schulman H, Heist K & Srinivasan M 1995 Decoding Ca2+ signals to the nucleus by multifunctional CaM kinase. Progress in Brain Research 105 95–104.[Web of Science][Medline]
Seger R & Krebs EG 1995 The MAPK signaling cascade. FASEB Journal 9 726–735.[Abstract]
Shi Y & Massague J 2003 Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 685–700.[CrossRef][Web of Science][Medline]
Shimonaka M, Inouye S, Shimasaki S & Ling N 1991 Follistatin binds to activin and inhibin through the common beta subunit. Endocrinology 130 3048–3056.
Shupnik MA 1990 GnRH effects on rat gonadotropin gene transcription in vitro: requirement for pulsatile administration for LH-ß gene stimulation. Molecular Endocrinology 4 1444–1450.
Shupnik MA 1996 Gonadotropin gene modulation by steroids and gonadotropin-releasing hormone. Biology of Reproduction 54 279–286.[Abstract]
Shupnik MA & Fallest PC 1994 Pulsatile GnRH regulation of gonadotropin subunit gene transcription. Neuroscience and Biobehavioral Reviews 18 597–599.[CrossRef][Web of Science][Medline]
Shupnik MA & Rosenzweig BA 1991 Identification of an estrogen-responsive element in the rat LH beta gene. DNA-estrogen receptor interactions and functional analysis. Journal of Biological Chemistry 266 17084–17091.
Shupnik MA, Gharib SD & Chin WW 1988 Estrogen suppresses rat gonadotropin gene transcription in vivo. Endocrinology 122 1842–1846.
Shupnik MA, Gharib SD & Chin WW 1989a Divergent effects of estradiol on gonadotropin gene transcription in pituitary fragments. Molecular Endocrinology 3 474–480.
Shupnik MA, Weinmann CM, Notides AC & Chin WW 1989b An upstream region of the rat luteinizing hormone beta gene binds estrogen receptor and confers estrogen responsiveness. Journal of Biological Chemistry 264 80–86.
Simard J, Labrie C, Hubert JF & Labrie F 1988 Modulation by sex steroids and [D-Trp6, Des-Gly-NH2(10)]luteinizing hormone (LH)-releasing hormone ethylamide of alpha-subunit and LH beta messenger ribonucleic acid levels in the rat anterior pituitary gland. Molecular Endocrinology 2 775–784.
Spady TJ, Shayya R, Thackray VG, Ehrensberger L, Bailey JS & Mellon PL 2004 Androgen regulates follicle-stimulating hormone ß gene expression in an activin-dependent manner in immortalized gonadotropes. Molecular Endocrinology 18 925–940.
Stojilkovic SS & Catt KJ 1995a Novel aspects of GnRH-induced intracellular signaling and secretion in pituitary gonadotrophs. Journal of Neuroendocrinology 7 739–757.[CrossRef][Web of Science][Medline]
Stojilkovic SS & Catt KJ 1995b Expression and signal transduction pathways of GnRH receptors. Recent Progress in Hormone Research 50 161–205.
Strahl BD, Huang HJ, Sebastian J, Ghosh BR & Miller WL 1998 Transcriptional activation of the ovine follicle-stimulating hormone beta-subunit gene by gonadotropin-releasing hormone: involvement of two activating protein-1-binding sites and protein kinase C. Endocrinology 139 4455–4465.
Sundaresan S, Colin IM, Pestell RG & Jameson JL 1996 Stimulation of MAPK by GnRH: evidence for the involvement of PKC. Endocrinology 137 304–311.[Abstract]
Suszko MI, Lo DJ, Suh H, Camper SA & Woodruff TK 2003 Regulation of the rat follicle-stimulating hormone ß-subunit promoter by activin. Molecular Endocrinology 17 318–332.
Tremblay JJ & Drouin J 1999 Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone beta gene transcription. Molecular and Cellular Biology 19 2567–2576.
Tse A & Hille B 1992 GnRH-induced calcium oscillations and rhythmic hyperpolarizations of pituitary gonadotropes. Science 255 462–464.
Turgeon JL, Kimura Y, Waring DW & Mellon PL 1996 Steroid and pulsatile gonadotropin-releasing hormone (GnRH) regulation of luteinizing hormone and GnRH receptor in a novel gonadotrope cell line. Molecular Endocrinology 10 439–450.
Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D & Spiess J 1986 Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321 776–779.[CrossRef][Medline]
Vasilyev VV, Lawson MA, Dipaolo D, Webster NJ & Mellon PL 2002a Different signaling pathways control acute induction versus long-term repression of LH beta transcription by GnRH. Endocrinology 143 3414–3426.
Vasilyev VV, Pernasetti F, Rosenberg SB, Barsoum MJ, Austin DA, Webster NJG & Mellon PL 2002b Transcriptional activation of the ovine FSH beta gene by GnRH involves multiple signal transduction pathways. Endocrinology 143 1651–1659.
Villalobos C, Faught WJ & Frawley LS 1998 Dynamic changes in spontaneous intracellular free calcium oscillations and their relationship to prolactin gene expression in single, primary mammotropes. Molecular Endocrinology 12 87–95.
Webster JC, Pedersen NR, Edwards DP, Beck CA & Miller WL 1995 The 5'-flanking region of the ovine follicle-stimulating hormone-beta gene contains six progesterone response elements: three proximal elements are sufficient to increase transcription in the presence of progesterone. Endocrinology 136 1049–1058.[Abstract]
Weck J, Fallest PC, Pitt LK & Shupnik MA 1998 Differential gonadotropin-releasing hormone stimulation of rat luteinizing hormone subunit gene transcription by calcium influx and mitogen-activated protein kinase-signaling pathways. Molecular Endocrinology 12 451–457.
Weck J, Anderson AC, Jenkins S, Fallest PC & Shupnik MA 2000 Divergent and composite gonadotropin-releasing hormone-responsive elements in the rat luteinizing hormone subunit genes. Molecular Endocrinology 14 472–485.
Weiss J, Jameson JL, Burrin JM & Crowley WF 1990 Divergent responses of gonadotropin subunit messenger RNAs to continuous versus pulsatile gonadotropin-releasing hormone in vitro. Molecular Endocrinology 4 557–564.
Weiss J, Crowley WF & Jameson JL 1992 Pulsatile gonadotropin-releasing hormone modifies polyadenylation of gonadotropin subunit messenger ribonucleic acids. Endocrinology 130 415–420.
Weiss J, Crowley WF Jr, Halvorson LM & Jameson JL 1993 Perifusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion. Endocrinology 132 2307–2311.
Weiss J, Guendner MJ, Halvorson LM & Jameson JL 1995 Transcriptional activation of the follicle-stimulating hormone ß-subunit gene by activin. Endocrinology 136 1885–1891.[Abstract]
White BR, Duval DL, Mulvaney JM, Roberson MS & Clay CM 1999 Homologous regulation of the gonadotropin-releasing hormone receptor gene is partially mediated by protein kinase C activation of an activator protein-1 element. Molecular Endocrinology 13 566–577.
Whitmarsh AJ, Yang SH, Su MSS, Sharrocks AD & Davis RJ 1997 Role of p38 and JNK MAP kinases in the activation of ternary complex factors. Molecular and Cellular Biology 17 2360–2371.[Abstract]
Wierman ME & Wang C 1990 Androgen selectively stimulates follicle-stimulating hormone-beta mRNA levels after gonadotropin-releasing hormone antagonist administration. Biology of Reproduction 42 563–571.[Abstract]
Wierman ME, Gharib SD, LaRovere JM, Badger TM & Chin WW 1988 Selective failure of androgens to regulate follicle stimulating hormone beta messenger ribonucleic acid levels in the male rat. Molecular Endocrinology 2 492–498.
Wierman ME, Gharib SD, Wang C, LaRovere JM, Badger TM & Chin WW 1990 Divergent regulation of gonadotropin subunit mRNA levels by androgens in the female rat. Biology of Reproduction 43 191–195.[Abstract]
Winters SJ, Ishizaka K, Kitahara S, Troen P & Attardi B 1992 Effects of testosterone on gonadotropin subunit messenger ribonucleic acids in the presence or absence of gonadotropin-releasing hormone. Endocrinology 130 726–734.
Winters SJ, Dalkin AC & Tsuji T 1997 Evidence that pituitary adenylate cyclase activating polypeptide suppresses follicle-stimulating hormone-beta messenger ribonucleic acid levels by stimulating follistatin gene transcription. Endocrinology 134 4324–4329.
Winters SJ, Kawakami S, Sahu A & Plant TM 2001 Pituitary follistatin and activin gene expression, and the testicular regulation of FSH in the adult rhesus monkey (Macaca mulatta). Endocrinology 142 2874–2878.
Wolfe M & Call GB 1999 Egr-1 binds the LH beta promoter and mediates GnRH-stimulated gene expression. Molecular Endocrinology 13 752–763.
Woodruff TK, Besecke LM, Groome N, Draper LB, Schwartz NB & Weiss J 1996 Inhibin A and inhibin B are inversely correlated to follicle-stimulating hormone, yet are discordant during the follicular phase of the rat estrous cycle, and inhibin A is expressed in a sexually dimorphic manner. Endocrinology 137 5463–5467.[Abstract]
Woodruff TK, Krummen LA, Lyon RJ, Stocks DL & Mather J 1993 Recombinant human inhibin A and recombinant human activin A regulate pituitary and ovarian function in the adult female rat. Endocrinology 132 2332–2341.
Wu FCW, Butler GE, Kelnar CJH & Sellar RE 1990 Patterns of pulsatile LH secretion before and during the onset of puberty in boys: a study using an immunoradiometric assay. Journal of Clinical Endocrinology and Metabolism 70 629–637.
Yasin M, Dalkin AC, Haisenleder DJ & Marshall JC 1996 Testosterone is required for gonadotropin-releasing hormone stimulation of luteinizing hormone-beta messenger ribonucleic acid expression in female rats. Endocrinology 137 1265–1271.[Abstract]
Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT & Wang XF 1997 Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Molecular and Cellular Biology 17 7019–7028.[Abstract]
Yokoi T, Ohmichi M, Tasaka K, Kimura A, Kanda Y, Hayakawa J, Tahara M, Hisamoto K, Kurachi H & Murata Y 2000 Activation of the luteinizing hormone beta promoter by gonadotropin-releasing hormone requires c-Jun NH2-terminal protein kinase. Journal of Biological Chemistry 275 21639–21647.
Zhang Y, Feng X, We R & Derynck R 1996 Receptor-associated MAD homologues synergize as effectors of the TGF-beta response. Nature 383 168–172.[CrossRef][Medline]
Zmeili SM, Papavasiliou SS, Thorner MO, Evans WS, Marshall JC & Landefeld TD 1986 Alpha and luteinizing hormone beta subunit messenger ribonucleic acids during the rat estrous cycle. Endocrinology 119 1867–1869.
Received 30 June 2004
Accepted 23 August 2004
Made available online as an Accepted Preprint 3 September 2004
This article has been cited by other articles:
|
|
 |
|
  T. Takeda, Y. Matsumoto, T. Koga, J. Mutoh, Y. Nishimura, T. Shimazoe, Y. Ishii, T. Ishida, and H. Yamada Maternal Exposure to Dioxin Disrupts Gonadotropin Production in Fetal Rats and Imprints Defects in Sexual Behavior J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1091 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. G. Thackray, J. L. Hunnicutt, A. K. Memon, Y. Ghochani, and P. L. Mellon Progesterone Inhibits Basal and Gonadotropin-Releasing Hormone Induction of Luteinizing Hormone {beta}-Subunit Gene Expression Endocrinology, May 1, 2009; 150(5): 2395 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Blount, K. Schmidt, N. J. Justice, W. W. Vale, W. H. Fischer, and L. M. Bilezikjian FoxL2 and Smad3 Coordinately Regulate Follistatin Gene Transcription J. Biol. Chem., March 20, 2009; 284(12): 7631 - 7645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-H. T. Do, S. J. Santos, and M. A. Lawson GNRH Induces the Unfolded Protein Response in the L{beta}T2 Pituitary Gonadotrope Cell Line Mol. Endocrinol., January 1, 2009; 23(1): 100 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, J. Fortin, P. Lamba, M. Bonomi, L. Persani, M. S. Roberson, and D. J. Bernard Activator Protein-1 and Smad Proteins Synergistically Regulate Human Follicle-Stimulating Hormone {beta}-Promoter Activity Endocrinology, November 1, 2008; 149(11): 5577 - 5591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Burger, D. J. Haisenleder, K. W. Aylor, and J. C. Marshall Regulation of Intracellular Signaling Cascades by GNRH Pulse Frequency in the Rat Pituitary: Roles for CaMK II, ERK, and JNK Activation Biol Reprod, November 1, 2008; 79(5): 947 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Ciccone, C. T. Lacza, M. Y. Hou, S. J. Gregory, K.-Y. Kam, S. Xu, and U. B. Kaiser A Composite Element that Binds Basic Helix Loop Helix and Basic Leucine Zipper Transcription Factors Is Important for Gonadotropin-Releasing Hormone Regulation of the Follicle-Stimulating Hormone {beta} Gene Mol. Endocrinol., August 1, 2008; 22(8): 1908 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Glidewell-Kenney, J. Weiss, L. A. Hurley, J. E. Levine, and J. L. Jameson Estrogen Receptor {alpha} Signaling Pathways Differentially Regulate Gonadotropin Subunit Gene Expression and Serum Follicle-Stimulating Hormone in the Female Mouse Endocrinology, August 1, 2008; 149(8): 4168 - 4176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Blount, J. M. Vaughan, W. W. Vale, and L. M. Bilezikjian A Smad-binding Element in Intron 1 Participates in Activin-dependent Regulation of the Follistatin Gene J. Biol. Chem., March 14, 2008; 283(11): 7016 - 7026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Thackray and P. L. Mellon Synergistic Induction of Follicle-Stimulating Hormone {beta}-Subunit Gene Expression by Gonadal Steroid Hormone Receptors and Smad Proteins Endocrinology, March 1, 2008; 149(3): 1091 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Casella, H. Lindner, C. Zenzmaier, D. Riitano, P. Berger, and T. Costa Non-Gonadotropin-Releasing Hormone-Mediated Transcription and Secretion of Large Human Glycoprotein Hormone {alpha}-Subunit in Human Embryonic Kidney-293 Cells Endocrinology, March 1, 2008; 149(3): 1144 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Gieske, H. J. Kim, S. J. Legan, Y. Koo, A. Krust, P. Chambon, and C. Ko Pituitary Gonadotroph Estrogen Receptor-{alpha} Is Necessary for Fertility in Females Endocrinology, January 1, 2008; 149(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F Y Cheng, C.-W. Yuen, and W. Ge Evidence for the existence of a local activin follistatin negative feedback loop in the goldfish pituitary and its regulation by activin and gonadal steroids J. Endocrinol., December 1, 2007; 195(3): 373 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kitahashi, S. Ogawa, T. Soga, Y. Sakuma, and I. Parhar Sexual Maturation Modulates Expression of Nuclear Receptor Types in Laser-Captured Single Cells of the Cichlid (Oreochromis niloticus) Pituitary Endocrinology, December 1, 2007; 148(12): 5822 - 5830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhu, A. S. Gleiberman, and M. G. Rosenfeld Molecular Physiology of Pituitary Development: Signaling and Transcriptional Networks Physiol Rev, July 1, 2007; 87(3): 933 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Shafiee-Kermani, S.-o. Han, and W. L. Miller Chronic Gonadotropin-Releasing Hormone Inhibits Activin Induction of the Ovine Follicle-Stimulating Hormone {beta}-Subunit: Involvement of 3',5'-Cyclic Adenosine Monophosphate Response Element Binding Protein and Nitric Oxide Synthase Type I Endocrinology, July 1, 2007; 148(7): 3346 - 3355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Burger, D. J. Haisenleder, G. M. Wotton, K. W. Aylor, A. C. Dalkin, and J. C. Marshall The regulation of FSHbeta transcription by gonadal steroids: testosterone and estradiol modulation of the activin intracellular signaling pathway Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E277 - E285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. McGillivray, V. G. Thackray, D. Coss, and P. L. Mellon Activin and Glucocorticoids Synergistically Activate Follicle-Stimulating Hormone {beta}-Subunit Gene Expression in the Immortalized L{beta}T2 Gonadotrope Cell Line Endocrinology, February 1, 2007; 148(2): 762 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ruf, M.-J. Park, F. Hayot, G. Lin, B. Roysam, Y. Ge, and S. C. Sealfon Mixed Analog/Digital Gonadotrope Biosynthetic Response to Gonadotropin-releasing Hormone J. Biol. Chem., October 13, 2006; 281(41): 30967 - 30978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Thackray, S. M. McGillivray, and P. L. Mellon Androgens, Progestins, and Glucocorticoids Induce Follicle-Stimulating Hormone {beta}-Subunit Gene Expression at the Level of the Gonadotrope Mol. Endocrinol., September 1, 2006; 20(9): 2062 - 2079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Wettschureck and S. Offermanns Mammalian G Proteins and Their Cell Type Specific Functions Physiol Rev, October 1, 2005; 85(4): 1159 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B Rulli and I. Huhtaniemi What have gonadotrophin overexpressing transgenic mice taught us about gonadal function? Reproduction, September 1, 2005; 130(3): 283 - 291. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
